Organism name | Theobroma cacao L. |
---|---|
Genus | Theobroma |
Family | Malvaceae |
Kingdom | Plantae |
Linked NCBI taxonomy name | Theobroma |
---|---|
Linked NCBI taxonomy ID | 3640 |
Linked level | genus |
Family in NCBI taxonomy | Malvaceae |
---|---|
ID | 3629 |
Kingdom (Superkingdom) in NCBI taxonomy | Viridiplantae |
---|---|
ID | 33090 |
Plant class | rosids |
---|---|
ID | 71275 |
Species | Activity |
---|---|
Theobroma cacao L. | 12-Lipoxygenase-Inhibitor |
Theobroma cacao L. | 15-Lipoxygenase-Inhibitor |
Theobroma cacao L. | 5-Lipoxygenase Inhibitor |
Theobroma cacao L. | A-beta-Blocker |
Theobroma cacao L. | ADD |
Theobroma cacao L. | Adenosis |
Theobroma cacao L. | Allergenic |
Theobroma cacao L. | Allergenic |
Theobroma cacao L. | Allergy |
Theobroma cacao L. | Alopecia |
Theobroma cacao L. | Analeptic |
Theobroma cacao L. | Analgesic |
Theobroma cacao L. | Angina |
Theobroma cacao L. | Antiadherent |
Theobroma cacao L. | Antiaggregant |
Theobroma cacao L. | Antialzheimeran |
Theobroma cacao L. | Antiapoptotic |
Theobroma cacao L. | Antibacterial |
Theobroma cacao L. | Anticariogenic |
Theobroma cacao L. | Antidepressant |
Theobroma cacao L. | Antidote |
Theobroma cacao L. | Antiglucosyltransferase |
Theobroma cacao L. | Antihemostatic |
Theobroma cacao L. | Antiinflammatory |
Theobroma cacao L. | Antileukotriene |
Theobroma cacao L. | AntiMDR |
Theobroma cacao L. | Antimutagenic |
Theobroma cacao L. | Antiobesity |
Theobroma cacao L. | Antioxidant |
Theobroma cacao L. | Antioxidant |
Theobroma cacao L. | Antiperoxidant |
Theobroma cacao L. | Antiplaque |
Theobroma cacao L. | Antiplatelet |
Theobroma cacao L. | Antiproliferant |
Theobroma cacao L. | Antiseptic |
Theobroma cacao L. | Antiseptic |
Theobroma cacao L. | Antitumor |
Theobroma cacao L. | Antitumor |
Theobroma cacao L. | Aphrodisiac |
Theobroma cacao L. | Aphrodisiac |
Theobroma cacao L. | Arteriodilator |
Theobroma cacao L. | Asthma |
Theobroma cacao L. | Astringent |
Theobroma cacao L. | Astringent |
Theobroma cacao L. | Bacteria |
Theobroma cacao L. | Bactericide |
Theobroma cacao L. | Bite |
Theobroma cacao L. | Bleeding |
Theobroma cacao L. | Broncholytic |
Theobroma cacao L. | Broncholytic |
Theobroma cacao L. | Bronchorelaxant |
Theobroma cacao L. | Bronchosis |
Theobroma cacao L. | Burn |
Theobroma cacao L. | cAMP-Genic |
Theobroma cacao L. | Cardioprotective |
Theobroma cacao L. | Cardiotonic |
Theobroma cacao L. | Cardiotonic |
Theobroma cacao L. | Cellulite |
Theobroma cacao L. | Cerebrotonic |
Theobroma cacao L. | Chafing |
Theobroma cacao L. | Chemopreventive |
Theobroma cacao L. | Childbirth |
Theobroma cacao L. | CNS-Stimulant |
Theobroma cacao L. | CNS-Stimulant |
Theobroma cacao L. | Cold |
Theobroma cacao L. | Comedogenic |
Theobroma cacao L. | Comedogenic |
Theobroma cacao L. | Congestion |
Theobroma cacao L. | Cough |
Theobroma cacao L. | Cramp |
Theobroma cacao L. | Cystosis |
Theobroma cacao L. | Debility |
Theobroma cacao L. | Deobstruent |
Theobroma cacao L. | Dermatosis |
Theobroma cacao L. | Diabetes |
Theobroma cacao L. | Diarrhea |
Theobroma cacao L. | Digestive |
Theobroma cacao L. | Digestive |
Theobroma cacao L. | Diuretic |
Theobroma cacao L. | Diuretic |
Theobroma cacao L. | Dopaminergic |
Theobroma cacao L. | Ecbolic |
Theobroma cacao L. | Ecbolic |
Theobroma cacao L. | Eczema |
Theobroma cacao L. | Emmenagogue |
Theobroma cacao L. | Emmenagogue |
Theobroma cacao L. | Emollient |
Theobroma cacao L. | Emollient |
Theobroma cacao L. | Enterosis |
Theobroma cacao L. | Eruption |
Theobroma cacao L. | Euphoriant |
Theobroma cacao L. | Fever |
Theobroma cacao L. | Flu |
Theobroma cacao L. | Hemorrhoid |
Theobroma cacao L. | Hepatoprotective |
Theobroma cacao L. | Hepatosis |
Theobroma cacao L. | High Blood Pressure |
Theobroma cacao L. | Hyperkinesis |
Theobroma cacao L. | Hypoglycemic |
Theobroma cacao L. | Hypotensive |
Theobroma cacao L. | Hypotensive |
Theobroma cacao L. | Immunomodulator |
Theobroma cacao L. | Infection |
Theobroma cacao L. | Inflammation |
Theobroma cacao L. | Insectifuge |
Theobroma cacao L. | Insulinogenic |
Theobroma cacao L. | Interleukin-Inhibitor |
Theobroma cacao L. | Interleukinogenic |
Theobroma cacao L. | Iron-Chelator |
Theobroma cacao L. | Lactagogue |
Theobroma cacao L. | Lipolytic |
Theobroma cacao L. | Lipolytic |
Theobroma cacao L. | Malaria |
Theobroma cacao L. | Mastosis |
Theobroma cacao L. | Myocontractant |
Theobroma cacao L. | Myorelaxant |
Theobroma cacao L. | Myorelaxant |
Theobroma cacao L. | Nephrosis |
Theobroma cacao L. | Neuroprotective |
Theobroma cacao L. | Nipple |
Theobroma cacao L. | NO-Genic |
Theobroma cacao L. | NO-Inhibitor |
Theobroma cacao L. | Obesity |
Theobroma cacao L. | Ophthalmia |
Theobroma cacao L. | Parasiticide |
Theobroma cacao L. | Parasiticide |
Theobroma cacao L. | Parturition |
Theobroma cacao L. | Pregnancy |
Theobroma cacao L. | Proctosis |
Theobroma cacao L. | Prooxidant |
Theobroma cacao L. | Rheumatism |
Theobroma cacao L. | S-Adenosylmethionine-decarboxylase Inhibitor |
Theobroma cacao L. | Scabies |
Theobroma cacao L. | Screw Worm |
Theobroma cacao L. | Secretolytic |
Theobroma cacao L. | Secretolytic |
Theobroma cacao L. | Sedative |
Theobroma cacao L. | Snakebite |
Theobroma cacao L. | Stimulant |
Theobroma cacao L. | Stimulant |
Theobroma cacao L. | Thermogenic |
Theobroma cacao L. | Thermogenic |
Theobroma cacao L. | Thyroregulator |
Theobroma cacao L. | Thyroregulator |
Theobroma cacao L. | Thyrosis |
Theobroma cacao L. | TNFalpha-Inhibitor |
Theobroma cacao L. | Tonic |
Theobroma cacao L. | Tonic |
Theobroma cacao L. | Tumor |
Theobroma cacao L. | Vaginosis |
Theobroma cacao L. | Vasodilator |
Theobroma cacao L. | Vasodilator |
Theobroma cacao L. | Vermifuge |
Theobroma cacao L. | Virus |
Theobroma cacao L. | Vulnerary |
Theobroma cacao L. | Water Retention |
Theobroma cacao L. | Worm |
Theobroma cacao L. | Wound |
Theobroma cacao L. | Wrinkle |
KNApSAcK ID | name | ChEMBL link | CTD link |
# of proteins in
ChEMBL interaction / related OMIM / related KEGG DISEASE |
# of genes in
CTD interaction / related diseases |
KCF-S
cluster |
phytochemical
cluster |
figure |
---|---|---|---|---|---|---|---|---|
C00004266
![]() |
Cinaroside
/ Luteolin 7-glucoside / Luteolin-7-O-glucoside / Luteolin 7-O-beta-D-glucopyranoside |
CHEMBL233929
CHEMBL574683 CHEMBL1159535 CHEMBL1317166 |
C066408
|
26 / 31 / 53 | No. 2 | No. 15 |
![]() |
|
C00001017
![]() |
Cosmosiin
/ Apigenin 7-glucoside / (-)-Apigenin 7-glucoside / Apigenin 7-O-beta-D-glucopyranoside |
CHEMBL487995
CHEMBL487017 CHEMBL1591566 CHEMBL2165585 |
C057792
|
5 / 6 / 1 | No. 2 | No. 15 |
![]() |
|
C00031677
![]() |
Chrysoeriol 7-O-glucoside
/ Chrysoeriol 7-O-beta-D-glucopyranoside |
CHEMBL486391
|
No. 2 | No. 15 |
![]() |
|||
C00005372
![]() |
Hyperin
/ Hyperoside / Quercetin 3-O-galactoside / Quercetin 3-O-beta-D-galactoside / Quercetin 3-beta-galactopyranoside / Quercetin 3-O-beta-D-galactopyranoside |
CHEMBL33027
CHEMBL309323 CHEMBL250450 CHEMBL251254 CHEMBL457304 CHEMBL1098724 CHEMBL2337335 CHEMBL2337336 |
C021304
|
38 / 43 / 34 | 4 / 0 | No. 2 | No. 15 |
![]() |
C00005373
![]() |
Hirsutrin
/ Isoquercetin / Isoquercetrin / (-)-Isoquercetrin / Quercetin 3-glucoside / Quercetin 3-O-beta-D-glucoside / Quercetin-3-O-beta-D-glucopyranoside / Quercetin 3-O-beta-D-glucopyranoside / (-)-Quercetin-3-O-beta-D-glucopyranoside |
CHEMBL33027
CHEMBL309323 CHEMBL250450 CHEMBL251254 CHEMBL457304 CHEMBL1098724 CHEMBL2337335 CHEMBL2337336 |
38 / 43 / 34 | No. 2 | No. 15 |
![]() |
||
C00005368
![]() |
Guaijaverin
/ Quercetin 3-O-alpha-L-arabinopyranoside |
CHEMBL183031
CHEMBL185461 CHEMBL488198 CHEMBL464507 CHEMBL520637 |
C088178
|
No. 2 | No. 15 |
![]() |
||
C00009277
![]() |
Proanthocyanidin A1
|
CHEMBL286933
CHEMBL81646 CHEMBL450916 |
13 / 3 / 4 | No. 16 | No. 19 |
![]() |
||
C00036803
![]() |
bis-8,8'-Catechinylmethane
|
No. 16 | No. 19 |
![]() |
||||
C00001110
![]() |
Vitexin
/ Apigenin 8-C-glucoside / 8-D-Glucosyl-4',5,7-trihydroxyflavone / 8-beta-D-Glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL487417
CHEMBL1332209 CHEMBL1357921 |
16 / 4 / 8 | No. 22 | No. 15 |
![]() |
||
C00001059
![]() |
Isovitexin
/ Saponaretin / Homovitexin / 6-C-beta-D-Glucopyranosylapigenin / 6-beta-D-Glucopyranosyl-4',5,7-trihydroxyflavone / 6-beta-D-Glucopyranosyl-5,7-dihydroxy-2-(4-hydroxyphenyl)-4H-1-benzopyran-4-one |
CHEMBL465360
CHEMBL1601394 |
C049772
|
28 / 20 / 19 | No. 22 | No. 15 |
![]() |
|
C00000947
![]() |
D-Catechol
/ D-Catechin / Teafuran 30A / (+)-Catechin / Dexcyanidanol / (+)-3',4',5,7-Tetrahydroxy-2,3-trans-flavan-3-ol |
CHEMBL80941
CHEMBL311498 CHEMBL129482 CHEMBL200715 CHEMBL206452 CHEMBL583912 |
D002392
|
85 / 58 / 54 | 91 / 13 | No. 52 | No. 14 |
![]() |
C00002668
![]() |
Protocatechuic acid
/ 3,4-Dihydroxybenzoic acid |
CHEMBL37537
|
C009091
|
33 / 19 / 19 | 2 / 0 | No. 817 | No. 81 |
![]() |
C00001510
![]() |
Theophylline
|
CHEMBL190
|
D013806
|
121 / 55 / 42 | 471 / 123 | No. 3446 | No. 12 |
![]() |
accession | description | class description | KNApSAcK metabolite in interactions |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|
Q9UNA4 | DNA polymerase iota | Enzyme | C00000947 C00001059 C00001110 C00002668 C00004266 C00005372 C00005373 | 0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | C00000947 C00001017 C00001059 C00001110 C00004266 C00005372 C00005373 | 0 / 0 |
O75496 | Geminin | Unclassified protein | C00001110 C00001510 C00002668 C00004266 C00005372 C00005373 | 0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | C00000947 C00001059 C00001110 C00004266 C00005372 C00005373 | 1 / 1 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | C00000947 C00001059 C00001110 C00004266 C00005372 C00005373 | 0 / 0 |
B2RXH2 | Lysine-specific demethylase 4E | Enzyme | C00000947 C00001059 C00002668 C00004266 C00005372 C00005373 | 0 / 0 |
Q9UIF8 | Bromodomain adjacent to zinc finger domain protein 2B | Unclassified protein | C00000947 C00001059 C00001510 C00005372 C00005373 | 0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | C00000947 C00001059 C00004266 C00005372 C00005373 | 0 / 0 |
P10636 | Microtubule-associated protein tau | Unclassified protein | C00000947 C00002668 C00004266 C00005372 C00005373 | 4 / 3 |
O94925 | Glutaminase kidney isoform, mitochondrial | Enzyme | C00001059 C00001110 C00002668 C00005372 C00005373 | 0 / 0 |
P06746 | DNA polymerase beta | Enzyme | C00000947 C00001059 C00002668 C00005372 C00005373 | 0 / 0 |
P10253 | Lysosomal alpha-glucosidase | Hydrolase | C00000947 C00001059 C00002668 C00005372 C00005373 | 1 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | C00001059 C00001110 C00002668 C00005372 C00005373 | 1 / 4 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | C00001059 C00001110 C00002668 C00005372 C00005373 | 0 / 1 |
Q9Y468 | Lethal(3)malignant brain tumor-like protein 1 | Unclassified protein | C00001059 C00001110 C00002668 C00004266 | 0 / 0 |
Q16637 | Survival motor neuron protein | Unclassified protein | C00000947 C00001017 C00005372 C00005373 | 4 / 1 |
P35372 | Mu-type opioid receptor | Opioid receptor | C00000947 C00001510 C00005372 C00005373 | 0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | C00000947 C00001510 C00005372 C00005373 | 0 / 0 |
P05186 | Alkaline phosphatase, tissue-nonspecific isozyme | Enzyme | C00000947 C00001510 C00005372 C00005373 | 3 / 1 |
P35354 | Prostaglandin G/H synthase 2 | Oxidoreductase | C00000947 C00001510 C00005372 C00005373 | 0 / 3 |
P41143 | Delta-type opioid receptor | Opioid receptor | C00000947 C00001510 C00005372 C00005373 | 0 / 0 |
P09923 | Intestinal-type alkaline phosphatase | Enzyme | C00000947 C00001510 C00005372 C00005373 | 0 / 0 |
P41145 | Kappa-type opioid receptor | Opioid receptor | C00000947 C00001510 C00005372 C00005373 | 0 / 0 |
P15121 | Aldose reductase | Enzyme | C00001110 C00002668 C00005372 C00005373 | 0 / 0 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | C00000947 C00001510 C00005372 C00005373 | 0 / 0 |
O00255 | Menin | Unclassified protein | C00000947 C00001059 C00004266 | 2 / 5 |
O75874 | Isocitrate dehydrogenase [NADP] cytoplasmic | Enzyme | C00001059 C00001510 C00004266 | 1 / 0 |
P17252 | Protein kinase C alpha type | Alpha | C00000947 C00001510 C00009277 | 0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | C00000947 C00001059 C00004266 | 1 / 1 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | C00000947 C00001110 C00001510 | 0 / 1 |
P05177 | Cytochrome P450 1A2 | Cytochrome P450 1A2 | C00000947 C00001110 C00001510 | 0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | C00001059 C00001110 C00004266 | 0 / 0 |
P46063 | ATP-dependent DNA helicase Q1 | Enzyme | C00000947 C00001059 C00004266 | 0 / 0 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | C00000947 C00001059 C00004266 | 1 / 2 |
P10696 | Alkaline phosphatase, placental-like | Enzyme | C00000947 C00005372 C00005373 | 0 / 1 |
Q9UNQ0 | ATP-binding cassette sub-family G member 2 | ATP binding cassette | C00001017 C00005372 C00005373 | 2 / 0 |
P18825 | Alpha-2C adrenergic receptor | Adrenergic receptor | C00001510 C00005372 C00005373 | 0 / 0 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | C00001059 C00005372 C00005373 | 1 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | C00000947 C00001110 C00001510 | 1 / 1 |
P47989 | Xanthine dehydrogenase/oxidase | Oxidoreductase | C00000947 C00005372 C00005373 | 1 / 1 |
P14679 | Tyrosinase | Oxidoreductase | C00004266 C00005372 C00005373 | 4 / 2 |
P00918 | Carbonic anhydrase 2 | Lyase | C00000947 C00001510 C00002668 | 1 / 2 |
P00352 | Retinal dehydrogenase 1 | Enzyme | C00000947 C00001059 C00004266 | 0 / 0 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | C00000947 C00001110 C00001510 | 0 / 1 |
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | C00000947 C00001110 C00001510 | 1 / 0 |
P06280 | Alpha-galactosidase A | Enzyme | C00005372 C00005373 | 1 / 1 |
P08908 | 5-hydroxytryptamine receptor 1A | Serotonin receptor | C00005372 C00005373 | 1 / 0 |
P34949 | Mannose-6-phosphate isomerase | Enzyme | C00005372 C00005373 | 1 / 1 |
P22748 | Carbonic anhydrase 4 | Lyase | C00000947 C00002668 | 1 / 1 |
P03372 | Estrogen receptor | NR3A1 | C00001510 C00002668 | 1 / 1 |
P02768 | Serum albumin | Secreted protein | C00000947 C00002668 | 0 / 0 |
Q96QE3 | ATPase family AAA domain-containing protein 5 | Unclassified protein | C00001059 C00004266 | 0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | C00005372 C00005373 | 11 / 10 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | C00000947 C00004266 | 3 / 3 |
Q16790 | Carbonic anhydrase 9 | Lyase | C00000947 C00002668 | 0 / 1 |
P14780 | Matrix metalloproteinase-9 | M10A | C00001510 C00002668 | 2 / 2 |
P43166 | Carbonic anhydrase 7 | Lyase | C00000947 C00002668 | 0 / 0 |
P07237 | Protein disulfide-isomerase | Enzyme | C00005372 C00005373 | 0 / 0 |
P04062 | Glucosylceramidase | Enzyme | C00005372 C00005373 | 6 / 4 |
Q05513 | Protein kinase C zeta type | Iota | C00000947 C00009277 | 0 / 0 |
Q13093 | Platelet-activating factor acetylhydrolase | Enzyme | C00000947 C00002668 | 3 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | C00001059 C00004266 | 0 / 0 |
Q04759 | Protein kinase C theta type | Delta | C00000947 C00009277 | 0 / 1 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | C00000947 C00001017 | 0 / 0 |
Q02156 | Protein kinase C epsilon type | Eta | C00000947 C00009277 | 0 / 0 |
O94806 | Serine/threonine-protein kinase D3 | Pkd | C00000947 C00009277 | 0 / 0 |
P23219 | Prostaglandin G/H synthase 1 | Oxidoreductase | C00000947 C00001510 | 0 / 0 |
Q05655 | Protein kinase C delta type | Delta | C00000947 C00009277 | 0 / 0 |
P05129 | Protein kinase C gamma type | Alpha | C00000947 C00009277 | 1 / 1 |
P05771 | Protein kinase C beta type | Alpha | C00000947 C00009277 | 0 / 0 |
P63092 | Guanine nucleotide-binding protein G(s) subunit alpha isoforms short | Other membrane protein | C00001059 C00001510 | 7 / 3 |
P23280 | Carbonic anhydrase 6 | Lyase | C00000947 C00002668 | 0 / 0 |
P03956 | Interstitial collagenase | M10A | C00001510 C00002668 | 0 / 1 |
P07711 | Cathepsin L1 | C1A | C00000947 C00002668 | 0 / 0 |
P00915 | Carbonic anhydrase 1 | Lyase | C00000947 C00002668 | 0 / 0 |
P24723 | Protein kinase C eta type | Eta | C00000947 C00009277 | 1 / 0 |
P41743 | Protein kinase C iota type | Iota | C00000947 C00009277 | 0 / 0 |
Q9ULX7 | Carbonic anhydrase 14 | Lyase | C00000947 C00002668 | 0 / 0 |
Q9NPH5 | NADPH oxidase 4 | Enzyme | C00005372 C00005373 | 0 / 0 |
Q15139 | Serine/threonine-protein kinase D1 | Pkd | C00000947 C00009277 | 0 / 0 |
Q14191 | Werner syndrome ATP-dependent helicase | Enzyme | C00001059 C00004266 | 2 / 1 |
O43570 | Carbonic anhydrase 12 | Lyase | C00000947 C00002668 | 1 / 2 |
P36888 | Receptor-type tyrosine-protein kinase FLT3 | Pdgfr | C00005372 C00005373 | 1 / 1 |
P11308 | Transcriptional regulator ERG | Unclassified protein | C00001510 | 1 / 2 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | C00001510 | 0 / 0 |
P17405 | Sphingomyelin phosphodiesterase | Enzyme | C00001059 | 2 / 2 |
P07998 | Ribonuclease pancreatic | Enzyme | C00000947 | 0 / 0 |
P84022 | Mothers against decapentaplegic homolog 3 | Unclassified protein | C00000947 | 2 / 0 |
P16581 | E-selectin | Adhesion | C00002668 | 0 / 0 |
P38398 | Breast cancer type 1 susceptibility protein | Enzyme | C00004266 | 4 / 2 |
P04035 | 3-hydroxy-3-methylglutaryl-coenzyme A reductase | Oxidoreductase | C00001510 | 0 / 0 |
P08913 | Alpha-2A adrenergic receptor | Adrenergic receptor | C00001510 | 0 / 0 |
P21917 | D(4) dopamine receptor | Dopamine receptor | C00001510 | 0 / 0 |
P30988 | Calcitonin receptor | Calcitonin receptor | C00001510 | 0 / 0 |
P35462 | D(3) dopamine receptor | Dopamine receptor | C00001510 | 1 / 0 |
P41968 | Melanocortin receptor 3 | Melanocortin receptor | C00001510 | 1 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | C00001510 | 0 / 1 |
P41595 | 5-hydroxytryptamine receptor 2B | Serotonin receptor | C00001510 | 0 / 0 |
P17948 | Vascular endothelial growth factor receptor 1 | Vegfr | C00001510 | 0 / 0 |
P25101 | Endothelin-1 receptor | Endothelin receptor | C00001510 | 0 / 0 |
P30411 | B2 bradykinin receptor | Bradykinin receptor | C00001510 | 0 / 0 |
P32245 | Melanocortin receptor 4 | Melanocortin receptor | C00001510 | 1 / 0 |
P50052 | Type-2 angiotensin II receptor | Angiotensin receptor | C00001510 | 1 / 1 |
P32238 | Cholecystokinin receptor type A | Cholecystokinin receptor | C00001510 | 0 / 0 |
P08311 | Cathepsin G | S1A | C00001510 | 0 / 0 |
Q9Y3R4 | Sialidase-2 | Enzyme | C00000947 | 0 / 0 |
Q99720 | Sigma non-opioid intracellular receptor 1 | Membrane receptor | C00001510 | 1 / 0 |
P25929 | Neuropeptide Y receptor type 1 | Neuropeptide Y receptor | C00001510 | 0 / 0 |
P32241 | Vasoactive intestinal polypeptide receptor 1 | Vasoactive intestinal peptide receptor | C00001510 | 0 / 0 |
P29274 | Adenosine receptor A2a | Adenosine receptor | C00001510 | 0 / 0 |
Q9Y271 | Cysteinyl leukotriene receptor 1 | Leukotriene receptor | C00001510 | 0 / 0 |
P37288 | Vasopressin V1a receptor | Vasopressin and oxytocin receptor | C00001510 | 0 / 0 |
P14416 | D(2) dopamine receptor | Dopamine receptor | C00001510 | 2 / 0 |
P11473 | Vitamin D3 receptor | NR1I1 | C00000947 | 2 / 3 |
P11509 | Cytochrome P450 2A6 | Cytochrome P450 2A6 | C00001510 | 0 / 0 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | C00001017 | 0 / 0 |
Q9NPD5 | Solute carrier organic anion transporter family member 1B3 | Electrochemical transporter | C00001510 | 1 / 0 |
P11021 | 78 kDa glucose-regulated protein | Unclassified protein | C00004266 | 0 / 0 |
P11388 | DNA topoisomerase 2-alpha | Isomerase | C00000947 | 0 / 0 |
P00734 | Prothrombin | S1A | C00000947 | 4 / 2 |
P04150 | Glucocorticoid receptor | NR3C1 | C00001510 | 0 / 1 |
P08172 | Muscarinic acetylcholine receptor M2 | Acetylcholine receptor | C00001510 | 2 / 0 |
P11229 | Muscarinic acetylcholine receptor M1 | Acetylcholine receptor | C00001510 | 0 / 0 |
P00533 | Epidermal growth factor receptor | TK tyrosine-protein kinase EGFR subfamily | C00001510 | 1 / 8 |
P21554 | Cannabinoid receptor 1 | Cannabinoid receptor | C00001510 | 0 / 0 |
P31645 | Sodium-dependent serotonin transporter | Serotonin | C00001510 | 2 / 0 |
P15692 | Vascular endothelial growth factor A | Secreted protein | C00009277 | 1 / 2 |
P04626 | Receptor tyrosine-protein kinase erbB-2 | TK tyrosine-protein kinase EGFR subfamily | C00001510 | 5 / 9 |
P20309 | Muscarinic acetylcholine receptor M3 | Acetylcholine receptor | C00001510 | 1 / 0 |
P21452 | Substance-K receptor | Neurokinin receptor | C00001510 | 0 / 0 |
P51679 | C-C chemokine receptor type 4 | CC chemokine receptor | C00001510 | 0 / 0 |
P51681 | C-C chemokine receptor type 5 | CC chemokine receptor | C00001510 | 3 / 0 |
P50406 | 5-hydroxytryptamine receptor 6 | Serotonin receptor | C00001510 | 0 / 0 |
P49763 | Placenta growth factor | Unclassified protein | C00009277 | 0 / 0 |
P04745 | Alpha-amylase 1 | Enzyme | C00000947 | 0 / 0 |
Q14123 | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C | PDE_1C | C00001510 | 0 / 0 |
P08581 | Hepatocyte growth factor receptor | TK tyrosine-protein kinase MET subfamily | C00000947 | 2 / 3 |
P41597 | C-C chemokine receptor type 2 | CC chemokine receptor | C00001510 | 1 / 0 |
P54132 | Bloom syndrome protein | Enzyme | C00000947 | 1 / 2 |
Q9GZT9 | Egl nine homolog 1 | Enzyme | C00002668 | 1 / 1 |
P08575 | Receptor-type tyrosine-protein phosphatase C | Enzyme | C00001510 | 2 / 1 |
P56817 | Beta-secretase 1 | A1A | C00000947 | 0 / 0 |
Q08209 | Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | Ser_Thr | C00001510 | 0 / 0 |
Q08828 | Adenylate cyclase type 1 | Enzyme | C00001510 | 0 / 0 |
P08253 | 72 kDa type IV collagenase | M10A | C00002668 | 1 / 3 |
P06241 | Tyrosine-protein kinase Fyn | Src | C00001510 | 0 / 0 |
P25024 | C-X-C chemokine receptor type 1 | CXC chemokine receptor | C00001510 | 0 / 0 |
P15428 | 15-hydroxyprostaglandin dehydrogenase [NAD(+)] | Enzyme | C00000947 | 2 / 2 |
Q01453 | Peripheral myelin protein 22 | Unclassified protein | C00000947 | 5 / 2 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | C00001510 | 0 / 0 |
P49327 | Fatty acid synthase | Transferase | C00000947 | 0 / 0 |
O76074 | cGMP-specific 3',5'-cyclic phosphodiesterase | PDE_5A | C00001510 | 0 / 0 |
P00374 | Dihydrofolate reductase | Oxidoreductase | C00000947 | 1 / 1 |
P13945 | Beta-3 adrenergic receptor | Adrenergic receptor | C00001510 | 0 / 0 |
P08588 | Beta-1 adrenergic receptor | Adrenergic receptor | C00001510 | 1 / 0 |
P22303 | Acetylcholinesterase | Hydrolase | C00001510 | 1 / 0 |
P28223 | 5-hydroxytryptamine receptor 2A | Serotonin receptor | C00001510 | 0 / 0 |
P28335 | 5-hydroxytryptamine receptor 2C | Serotonin receptor | C00001510 | 0 / 0 |
P08912 | Muscarinic acetylcholine receptor M5 | Acetylcholine receptor | C00001510 | 0 / 0 |
P08173 | Muscarinic acetylcholine receptor M4 | Acetylcholine receptor | C00001510 | 0 / 0 |
P25103 | Substance-P receptor | Neurokinin receptor | C00001510 | 0 / 0 |
P25105 | Platelet-activating factor receptor | PAF receptor | C00001510 | 0 / 0 |
P33032 | Melanocortin receptor 5 | Melanocortin receptor | C00001510 | 0 / 0 |
P19838 | Nuclear factor NF-kappa-B p105 subunit | Transcription Factor | C00000947 | 0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | C00000947 | 0 / 0 |
P14151 | L-selectin | Adhesion | C00002668 | 0 / 0 |
P16109 | P-selectin | Adhesion | C00002668 | 1 / 0 |
P30989 | Neurotensin receptor type 1 | Neurotensin receptor | C00001059 | 0 / 0 |
Q01959 | Sodium-dependent dopamine transporter | Dopamine | C00001510 | 1 / 0 |
P35367 | Histamine H1 receptor | Histamine receptor | C00001510 | 0 / 0 |
P05181 | Cytochrome P450 2E1 | Cytochrome P450 2E1 | C00001510 | 0 / 0 |
P25021 | Histamine H2 receptor | Histamine receptor | C00001510 | 0 / 0 |
Q6W5P4 | Neuropeptide S receptor | Neuropeptide receptor | C00000947 | 1 / 0 |
P21397 | Amine oxidase [flavin-containing] A | Oxidoreductase | C00001510 | 1 / 1 |
P07550 | Beta-2 adrenergic receptor | Adrenergic receptor | C00001510 | 0 / 1 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | C00000947 | 5 / 1 |
P29275 | Adenosine receptor A2b | Adenosine receptor | C00001510 | 0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | C00001059 | 0 / 0 |
P16473 | Thyrotropin receptor | Glycohormone receptor | C00000947 | 3 / 2 |
P23975 | Sodium-dependent noradrenaline transporter | Norepinephrine | C00001510 | 1 / 1 |
P25100 | Alpha-1D adrenergic receptor | Adrenergic receptor | C00001510 | 0 / 0 |
P30542 | Adenosine receptor A1 | Adenosine receptor | C00001510 | 0 / 0 |
P18089 | Alpha-2B adrenergic receptor | Adrenergic receptor | C00001510 | 0 / 0 |
P24557 | Thromboxane-A synthase | Cytochrome P450 5A1 | C00001510 | 1 / 1 |
P07451 | Carbonic anhydrase 3 | Lyase | C00000947 | 0 / 0 |
P06239 | Tyrosine-protein kinase Lck | Src | C00001510 | 0 / 1 |
O00408 | cGMP-dependent 3',5'-cyclic phosphodiesterase | PDE_2A | C00001510 | 0 / 0 |
P25025 | C-X-C chemokine receptor type 2 | CXC chemokine receptor | C00001510 | 0 / 0 |
P08254 | Stromelysin-1 | M10A | C00002668 | 1 / 0 |
Q9Y263 | Phospholipase A-2-activating protein | Unclassified protein | C00001510 | 0 / 0 |
Q9Y694 | Solute carrier family 22 member 7 | Unclassified protein | C00001510 | 0 / 0 |
P10415 | Apoptosis regulator Bcl-2 | Other cytosolic protein | C00000947 | 0 / 7 |
O15245 | Solute carrier family 22 member 1 | Drug uniporter | C00001510 | 0 / 0 |
P24298 | Alanine aminotransferase 1 | Enzyme | C00004266 | 0 / 0 |
P28907 | ADP-ribosyl cyclase 1 | Enzyme | C00000947 | 0 / 1 |
Q8N1Q1 | Carbonic anhydrase 13 | Lyase | C00000947 | 0 / 0 |
P52209 | 6-phosphogluconate dehydrogenase, decarboxylating | Enzyme | C00000947 | 0 / 0 |
P27361 | Mitogen-activated protein kinase 3 | Erk | C00001510 | 0 / 0 |
P29466 | Caspase-1 | C14 | C00001510 | 0 / 0 |
P22894 | Neutrophil collagenase | M10A | C00002668 | 0 / 0 |
P35218 | Carbonic anhydrase 5A, mitochondrial | Lyase | C00000947 | 0 / 0 |
Q9Y2D0 | Carbonic anhydrase 5B, mitochondrial | Lyase | C00000947 | 0 / 0 |
P49146 | Neuropeptide Y receptor type 2 | Neuropeptide Y receptor | C00001510 | 0 / 0 |
Q08493 | cAMP-specific 3',5'-cyclic phosphodiesterase 4C | PDE_4C | C00001510 | 0 / 0 |
Q07343 | cAMP-specific 3',5'-cyclic phosphodiesterase 4B | PDE_4B | C00001510 | 0 / 0 |
P27815 | cAMP-specific 3',5'-cyclic phosphodiesterase 4A | PDE_4A | C00001510 | 0 / 0 |
Q08499 | cAMP-specific 3',5'-cyclic phosphodiesterase 4D | PDE_4D | C00001510 | 1 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | C00001510 | 0 / 0 |
P33765 | Adenosine receptor A3 | Adenosine receptor | C00001510 | 0 / 0 |
P08246 | Neutrophil elastase | S1A | C00001510 | 2 / 1 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | C00001510 | 2 / 2 |
P21728 | D(1A) dopamine receptor | Dopamine receptor | C00001510 | 0 / 0 |
P09917 | Arachidonate 5-lipoxygenase | Oxidoreductase | C00002668 | 0 / 0 |
Q99700 | Ataxin-2 | Unclassified protein | C00004266 | 1 / 1 |
O94956 | Solute carrier organic anion transporter family member 2B1 | Unclassified protein | C00001510 | 0 / 0 |
Q9Y6L6 | Solute carrier organic anion transporter family member 1B1 | Electrochemical transporter | C00001510 | 1 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | C00004266 | 7 / 37 |
Q13370 | cGMP-inhibited 3',5'-cyclic phosphodiesterase B | PDE_3B | C00001510 | 0 / 0 |
Q14432 | cGMP-inhibited 3',5'-cyclic phosphodiesterase A | PDE_3A | C00001510 | 0 / 0 |
P54750 | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1A | PDE_1A | C00001510 | 0 / 0 |
Q01064 | Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1B | PDE_1B | C00001510 | 0 / 0 |
Q9NY46 | Sodium channel protein type 3 subunit alpha | SCN alpha, NaV1.x | C00001510 | 0 / 0 |
Q99250 | Sodium channel protein type 2 subunit alpha | SCN alpha, NaV1.x | C00001510 | 2 / 2 |
P35498 | Sodium channel protein type 1 subunit alpha | SCN alpha, NaV1.x | C00001510 | 3 / 2 |
P18031 | Tyrosine-protein phosphatase non-receptor type 1 | Tyr | C00000947 | 0 / 0 |
Q9H0H5 | Rac GTPase-activating protein 1 | Unclassified protein | C00000947 | 0 / 0 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | C00000947 | 3 / 0 |
Q13148 | TAR DNA-binding protein 43 | Unclassified protein | C00001510 | 1 / 1 |
gene | gene name | gene description | KNApSAcK metabolite in interactions |
---|---|---|---|
581 | BAX, BCL2L4 | BCL2-associated X protein |
C00000947
C00005372
|
7124 | TNF, DIF, TNF-alpha, TNFA, TNFSF2 | tumor necrosis factor |
C00000947
C00001510
|
5970 | RELA, NFKB3, p65 | v-rel avian reticuloendotheliosis viral oncogene homolog A |
C00000947
C00001510
|
54205 | CYCS, CYC, HCS, THC4 | cytochrome c, somatic |
C00000947
C00005372
|
4792 | NFKBIA, IKBA, MAD-3, NFKBI | nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha |
C00000947
C00001510
|
3689 | ITGB2, CD18, LAD, LCAMB, LFA-1, MAC-1, MF17, MFI7 | integrin, beta 2 (complement component 3 receptor 3 and 4 subunit) |
C00000947
C00001510
|
3559 | IL2RA, CD25, IDDM10, IL2R, TCGFR | interleukin 2 receptor, alpha |
C00000947
C00001510
|
3553 | IL1B, IL-1, IL1-BETA, IL1F2 | interleukin 1, beta |
C00000947
C00001510
|
595 | CCND1, BCL1, D11S287E, PRAD1, U21B31 | cyclin D1 |
C00000947
C00001510
|
6347 | CCL2, GDCF-2, HC11, HSMCR30, MCAF, MCP-1, MCP1, SCYA2, SMC-CF | chemokine (C-C motif) ligand 2 |
C00000947
C00001510
|
836 | CASP3, CPP32, CPP32B, SCA-1 | caspase 3, apoptosis-related cysteine peptidase (EC:3.4.22.56) |
C00000947
C00001510
|
596 | BCL2, Bcl-2, PPP1R50 | B-cell CLL/lymphoma 2 |
C00000947
C00001510
|
6948 | TCN2, D22S676, D22S750, II, TC, TC_II, TC-2, TC2, TCII | transcobalamin II |
C00001510
|
56751 | BARHL1 | BarH-like homeobox 1 |
C00000947
|
472 | ATM, AT1, ATA, ATC, ATD, ATDC, ATE, TEL1, TELO1 | ataxia telangiectasia mutated (EC:2.7.11.1) |
C00000947
|
637 | BID, FP497 | BH3 interacting domain death agonist |
C00000947
|
388962 | BOLA3, MMDS2 | bolA family member 3 |
C00000947
|
79184 | BRCC3, BRCC36, C6.1A, CXorf53 | BRCA1/BRCA2-containing complex, subunit 3 (EC:3.1.2.15) |
C00000947
|
694 | BTG1 | B-cell translocation gene 1, anti-proliferative |
C00000947
|
468 | ATF4, CREB-2, CREB2, TAXREB67, TXREB | activating transcription factor 4 |
C00000947
|
840 | CASP7, CASP-7, CMH-1, ICE-LAP3, LICE2, MCH3 | caspase 7, apoptosis-related cysteine peptidase (EC:3.4.22.60) |
C00000947
|
841 | CASP8, ALPS2B, CAP4, Casp-8, FLICE, MACH, MCH5 | caspase 8, apoptosis-related cysteine peptidase (EC:3.4.22.61) |
C00000947
|
842 | CASP9, APAF-3, APAF3, ICE-LAP6, MCH6, PPP1R56 | caspase 9, apoptosis-related cysteine peptidase (EC:3.4.22.62) |
C00000947
|
393 | ARHGAP4, C1, RGC1, RhoGAP4, SrGAP4, p115 | Rho GTPase activating protein 4 |
C00000947
|
302 | ANXA2, ANX2, ANX2L4, CAL1H, LIP2, LPC2, LPC2D, P36, PAP-IV | annexin A2 |
C00000947
|
930 | CD19, B4, CVID3 | CD19 molecule |
C00000947
|
975 | CD81, CVID6, S5.7, TAPA1, TSPAN28 | CD81 molecule |
C00000947
|
928 | CD9, BTCC-1, DRAP-27, MIC3, MRP-1, TSPAN-29, TSPAN29 | CD9 molecule |
C00000947
|
1054 | CEBPG, GPE1BP, IG/EBP-1 | CCAAT/enhancer binding protein (C/EBP), gamma |
C00000947
|
10978 | CLP1, HEAB, hClp1 | cleavage and polyadenylation factor I subunit 1 (EC:2.7.1.78) |
C00000947
|
10063 | COX17 | COX17 cytochrome c oxidase copper chaperone |
C00000947
|
3627 | CXCL10, C7, IFI10, INP10, IP-10, SCYB10, crg-2, gIP-10, mob-1 | chemokine (C-X-C motif) ligand 10 |
C00000947
|
1543 | CYP1A1, AHH, AHRR, CP11, CYP1, P1-450, P450-C, P450DX | cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) |
C00000947
|
7913 | DEK, D6S231E | DEK oncogene |
C00000947
|
1786 | DNMT1, ADCADN, AIM, CXXC9, DNMT, HSN1E, MCMT | DNA (cytosine-5-)-methyltransferase 1 (EC:2.1.1.37) |
C00000947
|
2130 | EWSR1, EWS, bK984G1.4 | EWS RNA-binding protein 1 |
C00000947
|
355 | FAS, ALPS1A, APO-1, APT1, CD95, FAS1, FASTM, TNFRSF6 | Fas cell surface death receptor |
C00000947
|
2323 | FLT3LG, FL, FLT3L | fms-related tyrosine kinase 3 ligand |
C00000947
|
2495 | FTH1, FHC, FTH, FTHL6, PIG15, PLIF | ferritin, heavy polypeptide 1 (EC:1.16.3.1) |
C00000947
|
2896 | GRN, CLN11, GEP, GP88, PCDGF, PEPI, PGRN | granulin |
C00000947
|
3014 | H2AFX, H2A.X, H2A/X, H2AX | H2A histone family, member X |
C00000947
|
3054 | HCFC1, CFF, HCF-1, HCF1, HFC1, MRX3, VCAF | host cell factor C1 (VP16-accessory protein) |
C00000947
|
3162 | HMOX1, HMOX1D, HO-1, HSP32, bK286B10 | heme oxygenase (decycling) 1 (EC:1.14.99.3) |
C00000947
|
3232 | HOXD3, HOX1D, HOX4, HOX4A, Hox-4.1 | homeobox D3 |
C00000947
|
3329 | HSPD1, CPN60, GROEL, HLD4, HSP-60, HSP60, HSP65, HuCHA60, SPG13 | heat shock 60kDa protein 1 (chaperonin) |
C00000947
|
3383 | ICAM1, BB2, CD54, P3.58 | intercellular adhesion molecule 1 |
C00000947
|
3586 | IL10, CSIF, GVHDS, IL-10, IL10A, TGIF | interleukin 10 |
C00000947
|
207 | AKT1, AKT, CWS6, PKB, PKB-ALPHA, PRKBA, RAC, RAC-ALPHA | v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) |
C00000947
|
9429 | ABCG2, ABC15, ABCP, BCRP, BCRP1, BMDP, CD338, CDw338, EST157481, GOUT1, MRX, MXR, MXR1, UAQTL1 | ATP-binding cassette, sub-family G (WHITE), member 2 |
C00000947
|
9235 | IL32, IL-32alpha, IL-32beta, IL-32delta, IL-32gamma, NK4, TAIF, TAIFa, TAIFb, TAIFc, TAIFd | interleukin 32 |
C00000947
|
3662 | IRF4, LSIRF, MUM1, NF-EM5 | interferon regulatory factor 4 |
C00000947
|
3683 | ITGAL, CD11A, LFA-1, LFA1A | integrin, alpha L (antigen CD11A (p180), lymphocyte function-associated antigen 1; alpha polypeptide) |
C00000947
|
23411 | SIRT1, SIR2L1 | sirtuin 1 |
C00005372
|
4067 | LYN, JTK8, p53Lyn, p56Lyn | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog (EC:2.7.10.2) |
C00000947
|
5604 | MAP2K1, CFC3, MAPKK1, MEK1, MKK1, PRKMK1 | mitogen-activated protein kinase kinase 1 (EC:2.7.12.2) |
C00000947
|
5605 | MAP2K2, CFC4, MAPKK2, MEK2, MKK2, PRKMK2 | mitogen-activated protein kinase kinase 2 (EC:2.7.12.2) |
C00000947
|
5594 | MAPK1, ERK, ERK2, ERT1, MAPK2, P42MAPK, PRKM1, PRKM2, p38, p40, p41, p41mapk | mitogen-activated protein kinase 1 (EC:2.7.11.24) |
C00000947
|
5595 | MAPK3, ERK-1, ERK1, ERT2, HS44KDAP, HUMKER1A, P44ERK1, P44MAPK, PRKM3, p44-ERK1, p44-MAPK | mitogen-activated protein kinase 3 (EC:2.7.11.24) |
C00000947
|
4282 | MIF, GIF, GLIF, MMIF | macrophage migration inhibitory factor (glycosylation-inhibiting factor) (EC:5.3.3.12 5.3.2.1) |
C00000947
|
64975 | MRPL41, BMRP, MRP-L27, MRPL27, RPML27 | mitochondrial ribosomal protein L41 |
C00000947
|
4493 | MT1E, MT1, MTD | metallothionein 1E |
C00000947
|
653361 | NCF1, NCF1A, NOXO2, SH3PXD1A, p47phox | neutrophil cytosolic factor 1 |
C00000947
|
4780 | NFE2L2, NRF2 | nuclear factor, erythroid 2-like 2 |
C00000947
|
2099 | ESR1, ER, ESR, ESRA, ESTRR, Era, NR3A1 | estrogen receptor 1 |
C00005372
|
4851 | NOTCH1, TAN1, hN1 | notch 1 |
C00000947
|
4869 | NPM1, B23, NPM | nucleophosmin (nucleolar phosphoprotein B23, numatrin) |
C00000947
|
5175 | PECAM1, CD31, CD31/EndoCAM, GPIIA', PECA1, PECAM-1, endoCAM | platelet/endothelial cell adhesion molecule 1 |
C00000947
|
5187 | PER1, PER, RIGUI, hPER | period circadian clock 1 |
C00000947
|
5327 | PLAT, T-PA, TPA | plasminogen activator, tissue (EC:3.4.21.68) |
C00000947
|
5328 | PLAU, ATF, BDPLT5, QPD, UPA, URK, u-PA | plasminogen activator, urokinase (EC:3.4.21.73) |
C00000947
|
7916 | PRRC2A, BAT2, D6S51, D6S51E, G2 | proline-rich coiled-coil 2A |
C00000947
|
5743 | PTGS2, COX-2, COX2, GRIPGHS, PGG/HS, PGHS-2, PHS-2, hCox-2 | prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase) (EC:1.14.99.1) |
C00000947
|
5747 | PTK2, FADK, FAK, FAK1, FRNK, PPP1R71, p125FAK, pp125FAK | protein tyrosine kinase 2 (EC:2.7.10.2) |
C00000947
|
5879 | RAC1, Rac-1, TC-25, p21-Rac1 | ras-related C3 botulinum toxin substrate 1 (rho family, small GTP binding protein Rac1) |
C00000947
|
5915 | RARB, HAP, NR1B2, RRB2 | retinoic acid receptor, beta |
C00000947
|
1312 | COMT | catechol-O-methyltransferase (EC:2.1.1.6) |
C00002668
|
6128 | RPL6, L6, SHUJUN-2, TAXREB107, TXREB1 | ribosomal protein L6 |
C00000947
|
6285 | S100B, NEF, S100, S100-B, S100beta | S100 calcium binding protein B |
C00000947
|
6286 | S100P, MIG9 | S100 calcium binding protein P |
C00000947
|
5054 | SERPINE1, PAI, PAI-1, PAI1, PLANH1 | serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 |
C00000947
|
7536 | SF1, BBP, D11S636, MBBP, ZCCHC25, ZFM1, ZNF162 | splicing factor 1 |
C00000947
|
6574 | SLC20A1, GLVR1, Glvr-1, PIT1, PiT-1 | solute carrier family 20 (phosphate transporter), member 1 |
C00000947
|
6699 | SPRR1B, CORNIFIN, GADD33, SPRR1 | small proline-rich protein 1B |
C00000947
|
6772 | STAT1, CANDF7, ISGF-3, STAT91 | signal transducer and activator of transcription 1, 91kDa |
C00000947
|
6777 | STAT5B, STAT5 | signal transducer and activator of transcription 5B |
C00000947
|
6778 | STAT6, D12S1644, IL-4-STAT, STAT6B, STAT6C | signal transducer and activator of transcription 6, interleukin-4 induced |
C00000947
|
6817 | SULT1A1, HAST1/HAST2, P-PST, PST, ST1A1, ST1A3, STP, STP1, TSPST1 | sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1 (EC:2.8.2.1) |
C00000947
|
6932 | TCF7, TCF-1 | transcription factor 7 (T-cell specific, HMG-box) |
C00000947
|
7083 | TK1, TK2 | thymidine kinase 1, soluble (EC:2.7.1.21) |
C00000947
|
2023 | ENO1, ENO1L1, MPB1, NNE, PPH | enolase 1, (alpha) (EC:4.2.1.11) |
C00002668
|
943 | TNFRSF8, CD30, D1S166E, Ki-1 | tumor necrosis factor receptor superfamily, member 8 |
C00000947
|
7150 | TOP1, TOPI | topoisomerase (DNA) I (EC:5.99.1.2) |
C00000947
|
7153 | TOP2A, TOP2, TP2A | topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) |
C00000947
|
2829 | XCR1, CCXCR1, GPR5 | chemokine (C motif) receptor 1 |
C00000947
|
51042 | ZNF593, ZT86 | zinc finger protein 593 |
C00000947
|
83451 | ABHD11, WBSCR21 | abhydrolase domain containing 11 |
C00001510
|
27 | ABL2, ABLL, ARG | c-abl oncogene 2, non-receptor tyrosine kinase (EC:2.7.10.2) |
C00001510
|
30 | ACAA1, ACAA, PTHIO, THIO | acetyl-CoA acyltransferase 1 (EC:2.3.1.16) |
C00001510
|
11332 | ACOT7, ACH1, ACT, BACH, CTE-II, LACH, LACH1, RP1-120G22.10, hBACH | acyl-CoA thioesterase 7 (EC:3.1.2.2) |
C00001510
|
59 | ACTA2, AAT6, ACTSA, MYMY5 | actin, alpha 2, smooth muscle, aorta |
C00001510
|
10097 | ACTR2, ARP2 | ARP2 actin-related protein 2 homolog (yeast) |
C00001510
|
10096 | ACTR3, ARP3 | ARP3 actin-related protein 3 homolog (yeast) |
C00001510
|
132612 | ADAD1, Tenr | adenosine deaminase domain containing 1 (testis-specific) |
C00001510
|
57188 | ADAMTSL3 | ADAMTS-like 3 |
C00001510
|
157 | ADRBK2, BARK2, GRK3 | adrenergic, beta, receptor kinase 2 (EC:2.7.11.15) |
C00001510
|
27125 | AFF4, AF5Q31, MCEF | AF4/FMR2 family, member 4 |
C00001510
|
3267 | AGFG1, HRB, RAB, RIP | ArfGAP with FG repeats 1 |
C00001510
|
25909 | AHCTF1, ELYS, MST108, TMBS62 | AT hook containing transcription factor 1 |
C00001510
|
84335 | AKT1S1, Lobe, PRAS40 | AKT1 substrate 1 (proline-rich) |
C00001510
|
230 | ALDOC, ALDC | aldolase C, fructose-bisphosphate (EC:4.1.2.13) |
C00001510
|
79796 | ALG9, CDG1L, DIBD1, LOH11CR1J | ALG9, alpha-1,2-mannosyltransferase (EC:2.4.1.259 2.4.1.261) |
C00001510
|
348094 | ANKDD1A | ankyrin repeat and death domain containing 1A |
C00001510
|
81573 | ANKRD13C, RP4-677H15.5, dJ677H15.3 | ankyrin repeat domain 13C |
C00001510
|
91526 | ANKRD44, PP6-ARS-B | ankyrin repeat domain 44 |
C00001510
|
26 | AOC1, ABP, ABP1, DAO, DAO1, KAO | amine oxidase, copper containing 1 (EC:1.4.3.22) |
C00001510
|
375 | ARF1 | ADP-ribosylation factor 1 |
C00001510
|
55843 | ARHGAP15, BM046 | Rho GTPase activating protein 15 |
C00001510
|
196528 | ARID2, BAF200, p200 | AT rich interactive domain 2 (ARID, RFX-like) |
C00001510
|
25852 | ARMC8, GID5, HSPC056, VID28 | armadillo repeat containing 8 |
C00001510
|
405 | ARNT, HIF-1-beta, HIF-1beta, HIF1-beta, HIF1B, HIF1BETA, TANGO, bHLHe2 | aryl hydrocarbon receptor nuclear translocator |
C00001510
|
411 | ARSB, ASB, G4S, MPS6 | arylsulfatase B (EC:3.1.6.12) |
C00001510
|
64422 | ATG3, APG3, APG3-LIKE, APG3L, PC3-96 | autophagy related 3 |
C00001510
|
27109 | ATP5S, ATPW, FB, HSU79253 | ATP synthase, H+ transporting, mitochondrial Fo complex, subunit s (factor B) (EC:3.6.1.14) |
C00001510
|
91647 | ATPAF2, ATP12, ATP12p, MC5DN1 | ATP synthase mitochondrial F1 complex assembly factor 2 |
C00001510
|
546 | ATRX, ATR2, JMS, MRXHF1, RAD54, RAD54L, SFM1, SHS, XH2, XNP, ZNF-HX | alpha thalassemia/mental retardation syndrome X-linked (EC:3.6.4.12) |
C00001510
|
9212 | AURKB, AIK2, AIM-1, AIM1, ARK2, AurB, IPL1, PPP1R48, STK12, STK5, aurkb-sv1, aurkb-sv2 | aurora kinase B (EC:2.7.11.1) |
C00001510
|
64343 | AZI2, AZ2, NAP1, TILP | 5-azacytidine induced 2 |
C00001510
|
148789 | B3GALNT2, B3GalNAc-T2, MDDGA11 | beta-1,3-N-acetylgalactosaminyltransferase 2 (EC:2.4.1.-) |
C00001510
|
11285 | B4GALT7, EDSP1, XGALT1, XGPT1 | xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (EC:2.4.1.133) |
C00001510
|
9529 | BAG5, BAG-5 | BCL2-associated athanogene 5 |
C00001510
|
9274 | BCL7C | B-cell CLL/lymphoma 7C |
C00001510
|
613 | BCR, ALL, BCR1, CML, D22S11, D22S662, PHL | breakpoint cluster region (EC:2.7.11.1) |
C00001510
|
29760 | BLNK, AGM4, BASH, BLNK-S, LY57, SLP-65, SLP65, bca | B-cell linker |
C00001510
|
2186 | BPTF, FAC1, FALZ, NURF301 | bromodomain PHD finger transcription factor |
C00001510
|
9577 | BRE, BRCC4, BRCC45 | brain and reproductive organ-expressed (TNFRSF1A modulator) |
C00001510
|
84280 | BTBD10, GMRP-1, GMRP1 | BTB (POZ) domain containing 10 |
C00001510
|
10950 | BTG3, ANA, TOB5, TOB55, TOFA | BTG family, member 3 |
C00001510
|
55216 | C11orf57 | chromosome 11 open reading frame 57 |
C00001510
|
730094 | C16orf52 | chromosome 16 open reading frame 52 |
C00001510
|
57020 | C16orf62 | chromosome 16 open reading frame 62 |
C00001510
|
148137 | C19orf55 | chromosome 19 open reading frame 55 |
C00001510
|
25912 | C1orf43, NICE-3, NS5ATP4, S863-3 | chromosome 1 open reading frame 43 |
C00001510
|
9847 | C2CD5, CDP138, KIAA0528 | C2 calcium-dependent domain containing 5 |
C00001510
|
84077 | C3orf20 | chromosome 3 open reading frame 20 |
C00001510
|
727 | C5, C5a, C5b, CPAMD4 | complement component 5 |
C00001510
|
817 | CAMK2D, CAMKD | calcium/calmodulin-dependent protein kinase II delta (EC:2.7.11.17) |
C00001510
|
55832 | CAND1, TIP120, TIP120A | cullin-associated and neddylation-dissociated 1 |
C00001510
|
4076 | CAPRIN1, GPIAP1, GPIP137, M11S1, RNG105, p137GPI | cell cycle associated protein 1 |
C00001510
|
829 | CAPZA1, CAPPA1, CAPZ, CAZ1 | capping protein (actin filament) muscle Z-line, alpha 1 |
C00001510
|
835 | CASP2, CASP-2, ICH1, NEDD-2, NEDD2, PPP1R57 | caspase 2, apoptosis-related cysteine peptidase (EC:3.4.22.55) |
C00001510
|
857 | CAV1, BSCL3, CGL3, MSTP085, PPH3, VIP21, CAV | caveolin 1, caveolae protein, 22kDa |
C00001510
|
81576 | CCDC130 | coiled-coil domain containing 130 |
C00001510
|
57821 | CCDC181, C1orf114, RP1-206D15.2 | coiled-coil domain containing 181 |
C00001510
|
728621 | CCDC30, PFD6L, PFDN6L | coiled-coil domain containing 30 |
C00001510
|
79780 | CCDC82, HSPC048 | coiled-coil domain containing 82 |
C00001510
|
54520 | CCDC93 | coiled-coil domain containing 93 |
C00001510
|
945 | CD33, SIGLEC-3, SIGLEC3, p67 | CD33 molecule |
C00001510
|
948 | CD36, BDPLT10, CHDS7, FAT, GP3B, GP4, GPIV, PASIV, SCARB3 | CD36 molecule (thrombospondin receptor) |
C00001510
|
920 | CD4, CD4mut | CD4 molecule |
C00001510
|
8621 | CDK13, CDC2L, CDC2L5, CHED, hCDK13 | cyclin-dependent kinase 13 (EC:2.7.11.23 2.7.11.22) |
C00001510
|
1027 | CDKN1B, CDKN4, KIP1, MEN1B, MEN4, P27KIP1 | cyclin-dependent kinase inhibitor 1B (p27, Kip1) |
C00001510
|
1028 | CDKN1C, BWCR, BWS, KIP2, WBS, p57, p57Kip2 | cyclin-dependent kinase inhibitor 1C (p57, Kip2) |
C00001510
|
80184 | CEP290, 3H11Ag, BBS14, CT87, JBTS5, LCA10, MKS4, NPHP6, POC3, SLSN6, rd16 | centrosomal protein 290kDa |
C00001510
|
80254 | CEP63 | centrosomal protein 63kDa |
C00001510
|
10390 | CEPT1 | choline/ethanolamine phosphotransferase 1 (EC:2.7.8.2 2.7.8.1) |
C00001510
|
1081 | CGA, CG-ALPHA, FSHA, GPHA1, GPHa, HCG, LHA, TSHA | glycoprotein hormones, alpha polypeptide |
C00001510
|
23274 | CLEC16A, Gop-1, KIAA0350 | C-type lectin domain family 16, member A |
C00001510
|
165530 | CLEC4F, CLECSF13, KCLR | C-type lectin domain family 4, member F |
C00001510
|
81570 | CLPB, HSP78, SKD3 | ClpB caseinolytic peptidase B homolog (E. coli) |
C00001510
|
1277 | COL1A1, OI4 | collagen, type I, alpha 1 |
C00001510
|
51117 | COQ4, CGI-92 | coenzyme Q4 |
C00001510
|
1329 | COX5B, COXVB | cytochrome c oxidase subunit Vb (EC:1.9.3.1) |
C00001510
|
1368 | CPM | carboxypeptidase M (EC:3.4.17.12) |
C00001510
|
8904 | CPNE1, COPN1, CPN1 | copine I |
C00001510
|
78987 | CRELD1, AVSD2, CIRRIN | cysteine-rich with EGF-like domains 1 |
C00001510
|
64784 | CRTC3, TORC-3, TORC3 | CREB regulated transcription coactivator 3 |
C00001510
|
1437 | CSF2, GMCSF | colony stimulating factor 2 (granulocyte-macrophage) |
C00001510
|
1440 | CSF3, C17orf33, CSF3OS, GCSF, G-CSF | colony stimulating factor 3 (granulocyte) |
C00001510
|
1454 | CSNK1E, CKIepsilon, HCKIE | casein kinase 1, epsilon (EC:2.7.11.1) |
C00001510
|
1503 | CTPS1, CTPS | CTP synthase 1 (EC:6.3.4.2) |
C00001510
|
1506 | CTRL, CTRL1 | chymotrypsin-like (EC:3.4.21.-) |
C00001510
|
1508 | CTSB, APPS, CPSB | cathepsin B (EC:3.4.22.1) |
C00001510
|
1544 | CYP1A2, CP12, P3-450, P450(PA) | cytochrome P450, family 1, subfamily A, polypeptide 2 (EC:1.14.14.1) |
C00001510
|
1571 | CYP2E1, CPE1, CYP2E, P450-J, P450C2E | cytochrome P450, family 2, subfamily E, polypeptide 1 (EC:1.14.13.n7) |
C00001510
|
1576 | CYP3A4, CP33, CP34, CYP3A, CYP3A3, CYPIIIA3, CYPIIIA4, HLP, NF-25, P450C3, P450PCN1 | cytochrome P450, family 3, subfamily A, polypeptide 4 (EC:1.14.13.67 1.14.13.97 1.14.13.32 1.14.13.157) |
C00001510
|
10800 | CYSLTR1, CYSLT1, CYSLT1R, CYSLTR, HMTMF81 | cysteinyl leukotriene receptor 1 |
C00001510
|
1601 | DAB2, DOC-2, DOC2 | Dab, mitogen-responsive phosphoprotein, homolog 2 (Drosophila) |
C00001510
|
147906 | DACT3, DAPPER3, RRR1 | dishevelled-binding antagonist of beta-catenin 3 |
C00001510
|
285761 | DCBLD1, dJ94G16.1 | discoidin, CUB and LCCL domain containing 1 |
C00001510
|
326709 |
C00001510
|
||
84301 | DDI2, RP4-680D5.5 | DNA-damage inducible 1 homolog 2 (S. cerevisiae) |
C00001510
|
308585 |
C00001510
|
||
1659 | DHX8, DDX8, HRH1, PRP22, PRPF22 | DEAH (Asp-Glu-Ala-His) box polypeptide 8 (EC:3.6.4.13) |
C00001510
|
1739 | DLG1, DLGH1, SAP-97, SAP97, dJ1061C18.1.1, hdlg | discs, large homolog 1 (Drosophila) |
C00001510
|
29103 | DNAJC15, DNAJD1, HSD18, MCJ | DnaJ (Hsp40) homolog, subfamily C, member 15 |
C00001510
|
3338 | DNAJC4, DANJC4, HSPF2, MCG18 | DnaJ (Hsp40) homolog, subfamily C, member 4 |
C00001510
|
9732 | DOCK4 | dedicator of cytokinesis 4 |
C00001510
|
22845 | DOLK, CDG1M, DK, DK1, SEC59, TMEM15 | dolichol kinase (EC:2.7.1.108) |
C00001510
|
116749 |
C00001510
|
||
1816 | DRD5, DBDR, DRD1B, DRD1L2 | dopamine receptor D5 |
C00001510
|
142679 | DUSP19, DUSP17, LMWDSP3, SKRP1, TS-DSP1 | dual specificity phosphatase 19 (EC:3.1.3.16 3.1.3.48) |
C00001510
|
124454 | EARS2, COXPD12, MSE1 | glutamyl-tRNA synthetase 2, mitochondrial (EC:6.1.1.17) |
C00001510
|
1906 | EDN1, ET1, HDLCQ7, PPET1 | endothelin 1 |
C00001510
|
112399 | EGLN3, HIFP4H3, HIFPH3, PHD3 | egl-9 family hypoxia-inducible factor 3 (EC:1.14.11.29) |
C00001510
|
1968 | EIF2S3, EIF2, EIF2G, EIF2gamma, eIF-2gA | eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa |
C00001510
|
8661 | EIF3A, EIF3, EIF3S10, P167, TIF32, eIF3-p170, eIF3-theta, p180, p185 | eukaryotic translation initiation factor 3, subunit A |
C00001510
|
8662 | EIF3B, EIF3-ETA, EIF3-P110, EIF3-P116, EIF3S9, PRT1 | eukaryotic translation initiation factor 3, subunit B |
C00001510
|
3646 | EIF3E, EIF3-P48, EIF3S6, INT6, eIF3-p46 | eukaryotic translation initiation factor 3, subunit E |
C00001510
|
1975 | EIF4B, EIF-4B, PRO1843 | eukaryotic translation initiation factor 4B |
C00001510
|
1983 | EIF5, EIF-5, EIF-5A | eukaryotic translation initiation factor 5 |
C00001510
|
54859 | ELP6, C3orf75, TMEM103 | elongator acetyltransferase complex subunit 6 |
C00001510
|
55831 | EMC3, POB, TMEM111 | ER membrane protein complex subunit 3 |
C00001510
|
957 | ENTPD5, CD39L4, NTPDase-5, PCPH | ectonucleoside triphosphate diphosphohydrolase 5 (EC:3.6.1.6 3.6.1.42) |
C00001510
|
57724 | EPG5, HEEW1, KIAA1632, VICIS, hEPG5 | ectopic P-granules autophagy protein 5 homolog (C. elegans) |
C00001510
|
2060 | EPS15, AF-1P, AF1P, MLLT5 | epidermal growth factor receptor pathway substrate 15 |
C00001510
|
54869 | EPS8L1, DRC3, EPS8R1 | EPS8-like 1 |
C00001510
|
2073 | ERCC5, COFS3, ERCM2, UVDR, XPG, XPGC | excision repair cross-complementing rodent repair deficiency, complementation group 5 |
C00001510
|
2077 | ERF, CRS4, PE-2, PE2 | Ets2 repressor factor |
C00001510
|
57222 | ERGIC1, ERGIC-32, ERGIC32, NET24 | endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1 |
C00001510
|
10613 | ERLIN1, C10orf69, Erlin-1, KE04, KEO4, SPFH1 | ER lipid raft associated 1 |
C00001510
|
11160 | ERLIN2, C8orf2, Erlin-2, NET32, SPFH2, SPG18 | ER lipid raft associated 2 |
C00001510
|
733318 |
C00001510
|
||
2124 | EVI2B, CD361, D17S376, EVDB | ecotropic viral integration site 2B |
C00001510
|
51010 | EXOSC3, PCH1B, RP11-3J10.8, RRP40, Rrp40p, bA3J10.7, hRrp-40, p10 | exosome component 3 |
C00001510
|
54512 | EXOSC4, RRP41, RRP41A, Rrp41p, SKI6, Ski6p, hRrp41p, p12A | exosome component 4 |
C00001510
|
2140 | EYA3 | eyes absent homolog 3 (Drosophila) (EC:3.1.3.48) |
C00001510
|
3995 | FADS3, CYB5RP, LLCDL3 | fatty acid desaturase 3 (EC:1.14.19.-) |
C00001510
|
55731 | FAM222B, C17orf63 | family with sequence similarity 222, member B |
C00001510
|
26269 | FBXO8, FBS, FBX8 | F-box protein 8 |
C00001510
|
9873 | FCHSD2, NWK, SH3MD3 | FCH and double SH3 domains 2 |
C00001510
|
2232 | FDXR, ADXR | ferredoxin reductase (EC:1.18.1.6) |
C00001510
|
2275 | FHL3, SLIM2 | four and a half LIM domains 3 |
C00001510
|
9158 | FIBP, FGFIBP, FIBP-1 | fibroblast growth factor (acidic) intracellular binding protein |
C00001510
|
81608 | FIP1L1, FIP1, Rhe, hFip1 | factor interacting with PAPOLA and CPSF1 |
C00001510
|
128486 | FITM2, C20orf142, Fit2, dJ881L22.2 | fat storage-inducing transmembrane protein 2 |
C00001510
|
2319 | FLOT2, ECS-1, ECS1, ESA, ESA1, M17S1 | flotillin 2 |
C00001510
|
23360 | FNBP4, FBP30 | formin binding protein 4 |
C00001510
|
2342 | FNTB, FPTB | farnesyltransferase, CAAX box, beta (EC:2.5.1.58) |
C00001510
|
2348 | FOLR1, FBP, FOLR | folate receptor 1 (adult) |
C00001510
|
2295 | FOXF2, FKHL6, FREAC-2, FREAC2 | forkhead box F2 |
C00001510
|
3607 | FOXK2, ILF, ILF-1, ILF1 | forkhead box K2 |
C00001510
|
83856 | FSD1L, CCDC10, CSDUFD1, FSD1CL, FSD1NL, MIR1 | fibronectin type III and SPRY domain containing 1-like |
C00001510
|
23710 | GABARAPL1, APG8-LIKE, APG8L, ATG8, ATG8B, ATG8L, GEC1 | GABA(A) receptor-associated protein like 1 |
C00001510
|
2570 | GABRR2 | gamma-aminobutyric acid (GABA) A receptor, rho 2 |
C00001510
|
9518 | GDF15, GDF-15, MIC-1, MIC1, NAG-1, PDF, PLAB, PTGFB | growth differentiation factor 15 |
C00001510
|
2673 | GFPT1, CMSTA1, GFA, GFAT, GFAT_1, GFAT1, GFAT1m, GFPT, GFPT1L, MSLG | glutamine--fructose-6-phosphate transaminase 1 (EC:2.6.1.16) |
C00001510
|
9453 | GGPS1, GGPPS, GGPPS1 | geranylgeranyl diphosphate synthase 1 (EC:2.5.1.1 2.5.1.10 2.5.1.29) |
C00001510
|
80318 | GKAP1, GKAP42 | G kinase anchoring protein 1 |
C00001510
|
10539 | GLRX3, GLRX4, GRX3, GRX4, PICOT, TXNL2, TXNL3 | glutaredoxin 3 |
C00001510
|
2744 | GLS, AAD20, GAC, GAM, GLS1, KGA | glutaminase (EC:3.5.1.2) |
C00001510
|
2782 | GNB1 | guanine nucleotide binding protein (G protein), beta polypeptide 1 |
C00001510
|
23131 | GPATCH8, GPATC8, KIAA0553 | G patch domain containing 8 |
C00001510
|
2823 | GPM6A, GPM6, M6A | glycoprotein M6A |
C00001510
|
283554 | GPR137C, TM7SF1L2 | G protein-coupled receptor 137C |
C00001510
|
2916 | GRM6, CSNB1B, GPRC1F, MGLUR6, mGlu6 | glutamate receptor, metabotropic 6 |
C00001510
|
2946 | GSTM2, GST4, GSTM, GSTM2-2, GTHMUS | glutathione S-transferase mu 2 (muscle) (EC:2.5.1.18) |
C00001510
|
3033 | HADH, HAD, HADH1, HADHSC, HCDH, HHF4, MSCHAD, SCHAD | hydroxyacyl-CoA dehydrogenase (EC:1.1.1.35) |
C00001510
|
24442 |
C00001510
|
||
3065 | HDAC1, GON-10, HD1, RPD3, RPD3L1 | histone deacetylase 1 (EC:3.5.1.98) |
C00001510
|
3066 | HDAC2, HD2, RPD3, YAF1 | histone deacetylase 2 (EC:3.5.1.98) |
C00001510
|
8841 | HDAC3, HD3, RPD3, RPD3-2 | histone deacetylase 3 (EC:3.5.1.98) |
C00001510
|
113510 | HELQ, HEL308 | helicase, POLQ-like (EC:3.6.4.12) |
C00001510
|
51409 | HEMK1, HEMK, MTQ1 | HemK methyltransferase family member 1 |
C00001510
|
11147 | HHLA3 | HERV-H LTR-associating 3 |
C00001510
|
3094 | HINT1, HINT, NMAN, PKCI-1, PRKCNH1 | histidine triad nucleotide binding protein 1 |
C00001510
|
8330 | HIST1H2AK, H2A/d, H2AFD | histone cluster 1, H2ak |
C00001510
|
8353 | HIST1H3E, H3.1, H3/d, H3FD | histone cluster 1, H3e |
C00001510
|
8337 | HIST2H2AA3, H2A, H2A.2, H2A/O, H2A/q, H2AFO, H2a-615, HIST2H2AA | histone cluster 2, H2aa3 |
C00001510
|
121504 | HIST4H4, H4/p | histone cluster 4, H4 |
C00001510
|
81502 | HM13, H13, IMP1, IMPAS, IMPAS-1, MSTP086, PSENL3, PSL3, SPP, SPPL1, dJ324O17.1 | histocompatibility (minor) 13 |
C00001510
|
3189 | HNRNPH3, 2H9, HNRPH3 | heterogeneous nuclear ribonucleoprotein H3 (2H9) |
C00001510
|
89781 | HPS4, LE | Hermansky-Pudlak syndrome 4 |
C00001510
|
3306 | HSPA2, HSP70-2, HSP70-3 | heat shock 70kDa protein 2 |
C00001510
|
27429 | HTRA2, OMI, PARK13, PRSS25 | HtrA serine peptidase 2 (EC:3.4.21.108) |
C00001510
|
3364 | HUS1, hHUS1 | HUS1 checkpoint homolog (S. pombe) |
C00001510
|
3386 | ICAM4, CD242, LW | intercellular adhesion molecule 4 (Landsteiner-Wiener blood group) |
C00001510
|
3425 | IDUA, IDA, MPS1 | iduronidase, alpha-L- (EC:3.2.1.76) |
C00001510
|
9592 | IER2, ETR101 | immediate early response 2 |
C00001510
|
3439 | IFNA1, IFL, IFN, IFN-ALPHA, IFN-alphaD, IFNA13, IFNA@ | interferon, alpha 1 |
C00001510
|
3458 | IFNG, IFG, IFI | interferon, gamma |
C00001510
|
55764 | IFT122, CED, CED1, SPG, WDR10, WDR10p, WDR140 | intraflagellar transport 122 homolog (Chlamydomonas) |
C00001510
|
55081 | IFT57, ESRRBL1, HIPPI, MHS4R2 | intraflagellar transport 57 homolog (Chlamydomonas) |
C00001510
|
8100 | IFT88, D13S1056E, DAF19, TG737, TTC10, hTg737 | intraflagellar transport 88 homolog (Chlamydomonas) |
C00001510
|
3488 | IGFBP5, IBP5 | insulin-like growth factor binding protein 5 |
C00001510
|
3549 | IHH, BDA1, HHG2 | indian hedgehog |
C00001510
|
121457 | IKBIP, IKIP | IKBKB interacting protein |
C00001510
|
3592 | IL12A, CLMF, IL-12A, NFSK, NKSF1, P35 | interleukin 12A (natural killer cell stimulatory factor 1, cytotoxic lymphocyte maturation factor 1, p35) |
C00001510
|
3593 | IL12B, CLMF, CLMF2, IL-12B, NKSF, NKSF2 | interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40) |
C00001510
|
3596 | IL13, IL-13, P600 | interleukin 13 |
C00001510
|
3606 | IL18, IGIF, IL-18, IL-1g, IL1F4 | interleukin 18 (interferon-gamma-inducing factor) |
C00001510
|
3562 | IL3, IL-3, MCGF, MULTI-CSF | interleukin 3 (colony-stimulating factor, multiple) |
C00001510
|
3565 | IL4, BCGF-1, BCGF1, BSF-1, BSF1, IL-4 | interleukin 4 |
C00001510
|
3569 | IL6, BSF2, HGF, HSF, IFNB2, IL-6 | interleukin 6 (interferon, beta 2) |
C00001510
|
3570 | IL6R, CD126, IL-6R-1, IL-6RA, IL6Q, IL6RA, IL6RQ, gp80 | interleukin 6 receptor |
C00001510
|
3572 | IL6ST, CD130, CDW130, GP130, IL-6RB | interleukin 6 signal transducer (gp130, oncostatin M receptor) |
C00001510
|
3576 | IL8, CXCL8, GCP-1, GCP1, LECT, LUCT, LYNAP, MDNCF, MONAP, NAF, NAP-1, NAP1 | interleukin 8 |
C00001510
|
3611 | ILK, ILK-1, ILK-2, P59, p59ILK | integrin-linked kinase (EC:2.7.11.1) |
C00001510
|
58493 | INIP, C9orf80, HSPC043, MISE, SOSSC, SSBIP1, hSSBIP1 | INTS3 and NABP interacting protein |
C00001510
|
3665 | IRF7, IRF-7H, IRF7A, IRF7B, IRF7C, IRF7H | interferon regulatory factor 7 |
C00001510
|
3667 | IRS1, HIRS-1 | insulin receptor substrate 1 |
C00001510
|
81533 | ITFG1, TIP | integrin alpha FG-GAP repeat containing 1 |
C00001510
|
3684 | ITGAM, CD11B, CR3A, MAC-1, MAC1A, MO1A, SLEB6 | integrin, alpha M (complement component 3 receptor 3 subunit) |
C00001510
|
9445 | ITM2B, ABRI, BRI, BRI2, BRICD2B, E25B, E3-16, FBD, imBRI2 | integral membrane protein 2B |
C00001510
|
79960 | JADE1, PHF17 | jade family PHD finger 1 |
C00001510
|
3716 | JAK1, JAK1A, JAK1B, JTK3 | Janus kinase 1 (EC:2.7.10.2) |
C00001510
|
779446 |
C00001510
|
||
3748 | KCNC3, KSHIIID, KV3.3, SCA13 | potassium voltage-gated channel, Shaw-related subfamily, member 3 |
C00001510
|
27345 | KCNMB4 | potassium large conductance calcium-activated channel, subfamily M, beta member 4 |
C00001510
|
23030 | KDM4B, JMJD2B, TDRD14B | lysine (K)-specific demethylase 4B |
C00001510
|
450566 |
C00001510
|
||
57587 | KIAA1430 |
C00001510
|
|
459808 |
C00001510
|
||
23095 | KIF1B, CMT2, CMT2A, CMT2A1, HMSNII, KLP, NBLST1 | kinesin family member 1B |
C00001510
|
22944 | KIN, BTCD, KIN17 | KIN, antigenic determinant of recA protein homolog (mouse) |
C00001510
|
3804 | KIR2DL3, CD158B2, CD158b, GL183, KIR-023GB, KIR-K7b, KIR-K7c, KIRCL23, NKAT, NKAT2, NKAT2A, NKAT2B, p58 | killer cell immunoglobulin-like receptor, two domains, long cytoplasmic tail, 3 |
C00001510
|
55975 | KLHL7, KLHL6, SBBI26 | kelch-like family member 7 |
C00001510
|
3915 | LAMC1, LAMB2 | laminin, gamma 1 (formerly LAMB2) |
C00001510
|
137994 | LETM2 | leucine zipper-EF-hand containing transmembrane protein 2 |
C00001510
|
10186 | LHFP | lipoma HMGIC fusion partner (EC:3.6.5.4) |
C00001510
|
3984 | LIMK1, LIMK, LIMK-1 | LIM domain kinase 1 (EC:2.7.11.1) |
C00001510
|
3991 | LIPE, HSL, LHS | lipase, hormone-sensitive (EC:3.1.1.79) |
C00001510
|
4023 | LPL, HDLCQ11, LIPD | lipoprotein lipase (EC:3.1.1.34) |
C00001510
|
10233 | LRRC23, LRPB7 | leucine rich repeat containing 23 |
C00001510
|
566017 |
C00001510
|
||
7940 | LST1, B144, D6S49E, LST-1 | leukocyte specific transcript 1 |
C00001510
|
4050 | LTB, TNFC, TNFSF3, p33 | lymphotoxin beta (TNF superfamily, member 3) |
C00001510
|
4056 | LTC4S | leukotriene C4 synthase (EC:4.4.1.20) |
C00001510
|
4057 | LTF, GIG12, HLF2, LF | lactotransferrin |
C00001510
|
127018 | LYPLAL1 | lysophospholipase-like 1 (EC:3.1.2.-) |
C00001510
|
93487 | MAPK1IP1L, C14orf32, MISS, c14_5346 | mitogen-activated protein kinase 1 interacting protein 1-like |
C00001510
|
5598 | MAPK7, BMK1, ERK4, ERK5, PRKM7 | mitogen-activated protein kinase 7 (EC:2.7.11.24) |
C00001510
|
4190 | MDH1, MDH-s, MDHA, MGC:1375, MOR2 | malate dehydrogenase 1, NAD (soluble) (EC:1.1.1.37 1.1.1.96) |
C00001510
|
23389 | MED13L, PROSIT240, THRAP2, TRAP240L | mediator complex subunit 13-like |
C00001510
|
10025 | MED16, DRIP92, THRAP5, TRAP95 | mediator complex subunit 16 |
C00001510
|
4205 | MEF2A, ADCAD1, RSRFC4, RSRFC9, mef2 | myocyte enhancer factor 2A |
C00001510
|
196074 | METTL15, METT5D1 | methyltransferase like 15 (EC:2.1.1.-) |
C00001510
|
10227 | MFSD10, TETRAN, TETTRAN | major facilitator superfamily domain containing 10 |
C00001510
|
4258 | MGST2, GST2, MGST-II | microsomal glutathione S-transferase 2 (EC:2.5.1.18) |
C00001510
|
284021 | MILR1, Allergin-1, C17orf60, MCA-32, MCA32 | mast cell immunoglobulin-like receptor 1 |
C00001510
|
79682 | CENPU, CENP50, CENPU50, KLIP1, MLF1IP, PBIP1 | centromere protein U |
C00001510
|
326625 | MMAB, ATR, cblB, cob | methylmalonic aciduria (cobalamin deficiency) cblB type (EC:2.5.1.17) |
C00001510
|
22879 | MON1B, HSRG1, SAND2, SRG1 | MON1 secretory trafficking family member B |
C00001510
|
10200 | MPHOSPH6, MPP, MPP-6, MPP6 | M-phase phosphoprotein 6 |
C00001510
|
4353 | MPO | myeloperoxidase (EC:1.11.2.2) |
C00001510
|
26164 | MTG2, GTPBP5, ObgH1, dJ1005F21.2 | mitochondrial ribosome-associated GTPase 2 |
C00001510
|
219402 | MTIF3, IF3mt | mitochondrial translational initiation factor 3 |
C00001510
|
25821 | MTO1, COXPD10 | mitochondrial tRNA translation optimization 1 |
C00001510
|
727897 | MUC5B, MG1, MUC-5B, MUC5, MUC9 | mucin 5B, oligomeric mucus/gel-forming |
C00001510
|
4609 | MYC, MRTL, MYCC, bHLHe39, c-Myc | v-myc avian myelocytomatosis viral oncogene homolog |
C00001510
|
80179 | MYO19, MYOHD1 | myosin XIX |
C00001510
|
440145 | MZT1, C13orf37, MOZART1 | mitotic spindle organizing protein 1 |
C00001510
|
10443 | N4BP2L2, 92M18.3, CG005, PFAAP5 | NEDD4 binding protein 2-like 2 |
C00001510
|
138151 | NACC2, BEND9, BTBD14, BTBD14A, BTBD31, RBB | NACC family member 2, BEN and BTB (POZ) domain containing |
C00001510
|
222236 | NAPEPLD, FMP30, NAPE-PLD | N-acyl phosphatidylethanolamine phospholipase D (EC:3.1.4.54) |
C00001510
|
79664 | NARG2, BRCC1 | NMDA receptor regulated 2 |
C00001510
|
65065 | NBEAL1, A530083I02Rik, ALS2CR16, ALS2CR17 | neurobeachin-like 1 |
C00001510
|
8440 | NCK2, GRB4, NCKbeta | NCK adaptor protein 2 |
C00001510
|
4708 | NDUFB2, AGGG, CI-AGGG | NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa (EC:1.6.5.3 1.6.99.3) |
C00001510
|
23327 | NEDD4L, NEDD4-2, NEDD4.2, RSP5, hNEDD4-2 | neural precursor cell expressed, developmentally down-regulated 4-like, E3 ubiquitin protein ligase (EC:6.3.2.-) |
C00001510
|
4790 | NFKB1, EBP-1, KBF1, NF-kB1, NF-kappa-B, NF-kappaB, NFKB-p105, NFKB-p50, NFkappaB, p105, p50 | nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 |
C00001510
|
51701 | NLK | nemo-like kinase (EC:2.7.11.24) |
C00001510
|
23530 | NNT, GCCD4 | nicotinamide nucleotide transhydrogenase (EC:1.6.1.2) |
C00001510
|
100301851 |
C00001510
|
||
23420 | NOMO1, Nomo, PM5 | NODAL modulator 1 |
C00001510
|
4835 | NQO2, DHQV, DIA6, NMOR2, QR2 | NAD(P)H dehydrogenase, quinone 2 (EC:1.10.99.2) |
C00001510
|
9315 | NREP, C5orf13, D4S114, P311, PRO1873, PTZ17, SEZ17 | neuronal regeneration related protein |
C00001510
|
9369 | NRXN3, C14orf60 | neurexin 3 |
C00001510
|
387338 | NSUN4, RP4-603I14.2, SHTAP | NOP2/Sun domain family, member 4 |
C00001510
|
10762 | NUP50, NPAP60, NPAP60L | nucleoporin 50kDa |
C00001510
|
10204 | NUTF2, NTF2, PP15 | nuclear transport factor 2 |
C00001510
|
54940 | OCIAD1, ASRIJ, OCIA, TPA018 | OCIA domain containing 1 |
C00001510
|
283694 | OR4N4, OR15-1, OR15-5 | olfactory receptor, family 4, subfamily N, member 4 |
C00001510
|
5007 | OSBP, OSBP1 | oxysterol binding protein |
C00001510
|
23440 | OTP | orthopedia homeobox |
C00001510
|
255967 | PAN3 | PAN3 poly(A) specific ribonuclease subunit homolog (S. cerevisiae) (EC:3.1.13.4) |
C00001510
|
142 | PARP1, ADPRT, ADPRT_1, ADPRT1, ARTD1, PARP, PARP-1, PPOL, pADPRT-1 | poly (ADP-ribose) polymerase 1 (EC:2.4.2.30) |
C00001510
|
100301806 |
C00001510
|
||
654790 | PCP4L1, IQM1 | Purkinje cell protein 4 like 1 |
C00001510
|
5125 | PCSK5, PC5, PC6, PC6A, SPC6, subtilase | proprotein convertase subtilisin/kexin type 5 (EC:3.4.21.-) |
C00001510
|
57107 | PDSS2, C6orf210, COQ10D3, DLP1, bA59I9.3, hDLP1 | prenyl (decaprenyl) diphosphate synthase, subunit 2 (EC:2.5.1.91) |
C00001510
|
8682 | PEA15, HMAT1, HUMMAT1H, MAT1, MAT1H, PEA-15, PED | phosphoprotein enriched in astrocytes 15 |
C00001510
|
5191 | PEX7, PBD9B, PTS2R, RCDP1, RD | peroxisomal biogenesis factor 7 |
C00001510
|
8554 | PIAS1, DDXBP1, GBP, GU/RH-II, ZMIZ3 | protein inhibitor of activated STAT, 1 |
C00001510
|
9063 | PIAS2, ARIP3, DIP, MIZ, MIZ1, PIASX, PIASX-ALPHA, PIASX-BETA, SIZ2, ZMIZ4 | protein inhibitor of activated STAT, 2 |
C00001510
|
8301 | PICALM, CALM, CLTH, LAP | phosphatidylinositol binding clathrin assembly protein |
C00001510
|
5279 | PIGC, GPI2 | phosphatidylinositol glycan anchor biosynthesis, class C (EC:2.4.1.198) |
C00001510
|
51268 | PIPOX, LPIPOX | pipecolic acid oxidase (EC:1.5.3.1 1.5.3.7) |
C00001510
|
23760 | PITPNB, PI-TP-beta, PtdInsTP, VIB1B | phosphatidylinositol transfer protein, beta |
C00001510
|
5314 | PKHD1, ARPKD, FCYT, TIGM1 | polycystic kidney and hepatic disease 1 (autosomal recessive) |
C00001510
|
23646 | PLD3, HU-K4, HUK4 | phospholipase D family, member 3 (EC:3.1.4.4) |
C00001510
|
59338 | PLEKHA1, TAPP1 | pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 1 |
C00001510
|
5356 | PLRG1, Cwc1, PRL1, PRP46, PRPF46, TANGO4 | pleiotropic regulator 1 |
C00001510
|
84172 | POLR1B, RPA135, RPA2, Rpo1-2 | polymerase (RNA) I polypeptide B, 128kDa (EC:2.7.7.6) |
C00001510
|
5435 | POLR2F, HRBP14.4, POLRF, RPABC2, RPB14.4, RPB6 | polymerase (RNA) II (DNA directed) polypeptide F (EC:2.7.7.6) |
C00001510
|
171568 | POLR3H, RPC22.9, RPC8 | polymerase (RNA) III (DNA directed) polypeptide H (22.9kD) (EC:2.7.7.6) |
C00001510
|
51728 | POLR3K, C11, C11-RNP3, RPC10, RPC11, RPC12.5, hRPC11 | polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa |
C00001510
|
5465 | PPARA, NR1C1, PPAR, PPARalpha, hPPAR | peroxisome proliferator-activated receptor alpha |
C00001510
|
5468 | PPARG, CIMT1, GLM1, NR1C3, PPARG1, PPARG2, PPARgamma | peroxisome proliferator-activated receptor gamma |
C00001510
|
5515 | PPP2CA, PP2Ac, PP2CA, PP2Calpha, RP-C | protein phosphatase 2, catalytic subunit, alpha isozyme (EC:3.1.3.16) |
C00001510
|
5532 | PPP3CB, CALNA2, CALNB, CNA2, PP2Bbeta | protein phosphatase 3, catalytic subunit, beta isozyme (EC:3.1.3.16) |
C00001510
|
5558 | PRIM2, PRIM2A, p58 | primase, DNA, polypeptide 2 (58kDa) (EC:2.7.7.-) |
C00001510
|
5562 | PRKAA1, AMPK, AMPKa1 | protein kinase, AMP-activated, alpha 1 catalytic subunit (EC:2.7.11.1 2.7.11.26 2.7.11.27 2.7.11.31) |
C00001510
|
5566 | PRKACA, PKACA | protein kinase, cAMP-dependent, catalytic, alpha (EC:2.7.11.11) |
C00001510
|
5578 | PRKCA, AAG6, PKC-alpha, PKCA, PRKACA | protein kinase C, alpha (EC:2.7.11.13) |
C00001510
|
8575 | PRKRA, DYT16, PACT, RAX | protein kinase, interferon-inducible double stranded RNA dependent activator |
C00001510
|
5618 | PRLR, hPRLrI | prolactin receptor |
C00001510
|
55119 | PRPF38B, NET1, RP11-293A10.1 | pre-mRNA processing factor 38B |
C00001510
|
7803 | PTP4A1, HH72, PRL-1, PRL1, PTP(CAAX1), PTPCAAX1 | protein tyrosine phosphatase type IVA, member 1 (EC:3.1.3.48) |
C00001510
|
5771 | PTPN2, PTN2, PTPT, TC-PTP, TCELLPTP, TCPTP | protein tyrosine phosphatase, non-receptor type 2 (EC:3.1.3.48) |
C00001510
|
5791 | PTPRE, HPTPE, PTPE, R-PTP-EPSILON | protein tyrosine phosphatase, receptor type, E (EC:3.1.3.48) |
C00001510
|
29920 | PYCR2, P5CR2 | pyrroline-5-carboxylate reductase family, member 2 (EC:1.5.1.2) |
C00001510
|
9230 | RAB11B, H-YPT3 | RAB11B, member RAS oncogene family |
C00001510
|
23011 | RAB21 | RAB21, member RAS oncogene family |
C00001510
|
5883 | RAD9A, RAD9 | RAD9 homolog A (S. pombe) (EC:3.1.11.2) |
C00001510
|
29098 | RANGRF, HSPC236, MOG1, RANGNRF | RAN guanine nucleotide release factor |
C00001510
|
9462 | RASAL2, NGAP | RAS protein activator like 2 |
C00001510
|
5925 | RB1, OSRC, RB, p105-Rb, pRb, pp110 | retinoblastoma 1 |
C00001510
|
9939 | RBM8A, BOV-1A, BOV-1B, BOV-1C, C1DELq21.1, DEL1q21.1, MDS014, RBM8, RBM8B, TAR, Y14, ZNRP, ZRNP1 | RNA binding motif protein 8A |
C00001510
|
149041 | RC3H1, RNF198, ROQUIN | ring finger and CCCH-type domains 1 |
C00001510
|
1827 | RCAN1, ADAPT78, CSP1, DSC1, DSCR1, MCIP1, RCN1 | regulator of calcineurin 1 |
C00001510
|
157506 | RDH10, SDR16C4 | retinol dehydrogenase 10 (all-trans) (EC:1.1.1.300) |
C00001510
|
8434 | RECK, ST15 | reversion-inducing-cysteine-rich protein with kazal motifs |
C00001510
|
5972 | REN, HNFJ2 | renin (EC:3.4.23.15) |
C00001510
|
55312 | RFK, RIFK | riboflavin kinase (EC:2.7.1.26) |
C00001510
|
23180 | RFTN1, PIB10, PIG9, RAFTLIN | raftlin, lipid raft linker 1 |
C00001510
|
431530 |
C00001510
|
||
6004 | RGS16, A28-RGS14, A28-RGS14P, RGS-R | regulator of G-protein signaling 16 |
C00001510
|
83695 | RHNO1, C12orf32, RHINO | RAD9-HUS1-RAD1 interacting nuclear orphan 1 |
C00001510
|
89941 | RHOT2, ARHT2, C16orf39, MIRO-2, MIRO2, RASL | ras homolog family member T2 (EC:3.6.5.-) |
C00001510
|
79608 | RIC3, AYST720, PRO1385 | RIC3 acetylcholine receptor chaperone |
C00001510
|
8780 | RIOK3, SUDD | RIO kinase 3 (EC:2.7.11.1) |
C00001510
|
11035 | RIPK3, RIP3 | receptor-interacting serine-threonine kinase 3 (EC:2.7.11.1) |
C00001510
|
64795 | RMND5A, CTLH, GID2, GID2A, RMD5, p44CTLH | required for meiotic nuclear division 5 homolog A (S. cerevisiae) |
C00001510
|
8635 | RNASET2, RNASE6PL, bA514O12.3 | ribonuclease T2 (EC:3.1.27.1) |
C00001510
|
6209 | RPS15, RIG, S15 | ribosomal protein S15 |
C00001510
|
157869 | SBSPON, C8orf84, RPESP | somatomedin B and thrombospondin, type 1 domain containing |
C00001510
|
9997 | SCO2, CEMCOX1, MYP6, SCO1L | SCO2 cytochrome c oxidase assembly protein |
C00001510
|
10993 | SDS, SDH | serine dehydratase (EC:4.3.1.17 4.3.1.19) |
C00001510
|
79048 | SECISBP2, SBP2 | SECIS binding protein 2 |
C00001510
|
6402 | SELL, CD62L, LAM1, LECAM1, LEU8, LNHR, LSEL, LYAM1, PLNHR, TQ1 | selectin L |
C00001510
|
5265 | SERPINA1, A1A, A1AT, AAT, PI, PI1, PRO2275, alpha1AT | serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 1 |
C00001510
|
29072 | SETD2, HBP231, HIF-1, HIP-1, HYPB, KMT3A, SET2, p231HBP | SET domain containing 2 (EC:2.1.1.43) |
C00001510
|
6439 | SFTPB, PSP-B, SFTB3, SFTP3, SMDP1, SP-B | surfactant protein B |
C00001510
|
9047 | SH2D2A, F2771, SCAP, TSAD, VRAP | SH2 domain containing 2A |
C00001510
|
57630 | SH3RF1, POSH, RNF142, SH3MD2 | SH3 domain containing ring finger 1 |
C00001510
|
257218 | SHPRH, bA545I5.2 | SNF2 histone linker PHD RING helicase, E3 ubiquitin protein ligase |
C00001510
|
100195279 |
C00001510
|
||
22933 | SIRT2, SIR2, SIR2L, SIR2L2 | sirtuin 2 (EC:3.5.1.-) |
C00001510
|
84561 | SLC12A8, CCC9 | solute carrier family 12, member 8 |
C00001510
|
56996 | SLC12A9, CCC6, CIP1, WO3.3, hCCC6 | solute carrier family 12, member 9 |
C00001510
|
6566 | SLC16A1, HHF7, MCT, MCT1 | solute carrier family 16 (monocarboxylate transporter), member 1 |
C00001510
|
29957 | SLC25A24, APC1, SCAMC-1 | solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 24 |
C00001510
|
55334 | SLC39A9, ZIP-9, ZIP9 | solute carrier family 39, member 9 |
C00001510
|
6528 | SLC5A5, NIS, TDH1 | solute carrier family 5 (sodium/iodide cotransporter), member 5 |
C00001510
|
7871 | SLMAP, SLAP | sarcolemma associated protein |
C00001510
|
4087 | SMAD2, JV18, JV18-1, MADH2, MADR2, hMAD-2, hSMAD2 | SMAD family member 2 |
C00001510
|
4090 | SMAD5, DWFC, JV5-1, MADH5 | SMAD family member 5 |
C00001510
|
57223 | SMEK2, FLFL2, PP4R3B, PSY2, smk1 | SMEK homolog 2, suppressor of mek1 (Dictyostelium) |
C00001510
|
79086 | SMIM7, C19orf42 | small integral membrane protein 7 |
C00001510
|
55234 | SMU1, BWD, RP11-54K16.3, SMU-1, fSAP57 | smu-1 suppressor of mec-8 and unc-52 homolog (C. elegans) |
C00001510
|
8773 | SNAP23, HsT17016, SNAP-23, SNAP23A, SNAP23B | synaptosomal-associated protein, 23kDa |
C00001510
|
724102 | SNHG4, NCRNA00059, U19H | small nucleolar RNA host gene 4 (non-protein coding) |
C00001510
|
23161 | SNX13, RGS-PX1 | sorting nexin 13 |
C00001510
|
26010 | SPATS2L, DNAPTP6, SGNP | spermatogenesis associated, serine-rich 2-like |
C00001510
|
63826 | SRR, ILV1, ISO1 | serine racemase (EC:4.3.1.17 5.1.1.18 4.3.1.18) |
C00001510
|
6428 | SRSF3, SFRS3, SRp20 | serine/arginine-rich splicing factor 3 |
C00001510
|
6745 | SSR1, TRAPA | signal sequence receptor, alpha |
C00001510
|
6747 | SSR3, TRAPG | signal sequence receptor, gamma (translocon-associated protein gamma) |
C00001510
|
6750 | SST, SMST | somatostatin |
C00001510
|
6487 | ST3GAL3, EIEE15, MRT12, SIAT6, ST3GALII, ST3GalIII, ST3N | ST3 beta-galactoside alpha-2,3-sialyltransferase 3 (EC:2.4.99.6) |
C00001510
|
10254 | STAM2, Hbp, STAM2A, STAM2B | signal transducing adaptor molecule (SH3 domain and ITAM motif) 2 |
C00001510
|
6774 | STAT3, APRF, HIES | signal transducer and activator of transcription 3 (acute-phase response factor) |
C00001510
|
8428 | STK24, MST3, MST3B, STE20, STK3 | serine/threonine kinase 24 (EC:2.7.11.1) |
C00001510
|
140901 | STK35, CLIK1, STK35L1 | serine/threonine kinase 35 (EC:2.7.11.1) |
C00001510
|
692637 |
C00001510
|
||
6830 | SUPT6H, SPT6, SPT6H, emb-5 | suppressor of Ty 6 homolog (S. cerevisiae) |
C00001510
|
440423 | SUZ12P1, SUZ12P | suppressor of zeste 12 homolog pseudogene 1 |
C00001510
|
6863 | TAC1, Hs.2563, NK2, NKNA, NPK, TAC2 | tachykinin, precursor 1 |
C00001510
|
9015 | TAF1A, MGC:17061, RAFI48, SL1, TAFI48 | TATA box binding protein (TBP)-associated factor, RNA polymerase I, A, 48kDa |
C00001510
|
6879 | TAF7, TAF2F, TAFII55 | TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa |
C00001510
|
80222 | TARS2, TARSL1, thrRS | threonyl-tRNA synthetase 2, mitochondrial (putative) (EC:6.1.1.3) |
C00001510
|
50840 | TAS2R14, T2R14, TRB1 | taste receptor, type 2, member 14 |
C00001510
|
6902 | TBCA | tubulin folding cofactor A |
C00001510
|
6916 | TBXAS1, BDPLT14, CYP5, CYP5A1, GHOSAL, THAS, TS, TXAS, TXS | thromboxane A synthase 1 (platelet) (EC:5.3.99.5) |
C00001510
|
6929 | TCF3, E2A, E47, ITF1, TCF-3, VDIR, bHLHb21 | transcription factor 3 |
C00001510
|
2683 | B4GALT1, B4GAL-T1, CDG2D, GGTB2, GT1, GTB, beta4Gal-T1 | UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1 (EC:2.4.1.22 2.4.1.90 2.4.1.38) |
C00000947
|
79736 | TEFM, C17orf42 | transcription elongation factor, mitochondrial |
C00001510
|
7016 | TESK1 | testis-specific kinase 1 (EC:2.7.12.1) |
C00001510
|
7040 | TGFB1, CED, DPD1, LAP, TGFB, TGFbeta | transforming growth factor, beta 1 |
C00001510
|
7050 | TGIF1, HPE4, TGIF | TGFB-induced factor homeobox 1 |
C00001510
|
79838 | TMC5 | transmembrane channel-like 5 |
C00001510
|
222068 | TMED4, ERS25, HNLF | transmembrane emp24 protein transport domain containing 4 |
C00001510
|
54664 | TMEM106B | transmembrane protein 106B |
C00001510
|
55266 | TMEM19 | transmembrane protein 19 |
C00001510
|
79161 | TMEM243, C7orf23, MM-TRAG | transmembrane protein 243, mitochondrial |
C00001510
|
54916 | TMEM260, C14orf101 | transmembrane protein 260 |
C00001510
|
9725 | TMEM63A, KIAA0792 | transmembrane protein 63A |
C00001510
|
283232 | TMEM80 | transmembrane protein 80 |
C00001510
|
84910 | TMEM87B | transmembrane protein 87B |
C00001510
|
54495 | TMX3, PDIA13, TXNDC10 | thioredoxin-related transmembrane protein 3 (EC:5.3.4.1) |
C00001510
|
25816 | TNFAIP8, GG2-1, MDC-3.13, NDED, SCC-S2, SCCS2 | tumor necrosis factor, alpha-induced protein 8 |
C00001510
|
7157 | TP53, BCC7, LFS1, P53, TRP53 | tumor protein p53 |
C00001510
|
7172 | TPMT | thiopurine S-methyltransferase (EC:2.1.1.67) |
C00001510
|
7174 | TPP2, TPP-2 | tripeptidyl peptidase II (EC:3.4.14.10) |
C00001510
|
7185 | TRAF1, EBI6, MGC:10353 | TNF receptor-associated factor 1 |
C00001510
|
89122 | TRIM4, RNF87 | tripartite motif containing 4 |
C00001510
|
93587 | TRMT10A, RG9MTD2, TRM10 | tRNA methyltransferase 10 homolog A (S. cerevisiae) |
C00001510
|
54482 | TRMT13, CCDC76 | tRNA methyltransferase 13 homolog (S. cerevisiae) (EC:2.1.1.225) |
C00001510
|
115708 | TRMT61A, C14orf172, GCD14, Gcd14p, TRM61, hTRM61 | tRNA methyltransferase 61 homolog A (S. cerevisiae) (EC:2.1.1.220) |
C00001510
|
54822 | TRPM7, ALSPDC, CHAK, CHAK1, LTRPC7, TRP-PLIK | transient receptor potential cation channel, subfamily M, member 7 (EC:2.7.11.1) |
C00001510
|
7267 | TTC3, DCRR1, RNF105, TPRDIII | tetratricopeptide repeat domain 3 |
C00001510
|
9652 | TTC37, KIAA0372, Ski3 | tetratricopeptide repeat domain 37 |
C00001510
|
26140 | TTLL3, HOTTL | tubulin tyrosine ligase-like family, member 3 |
C00001510
|
7273 | TTN, CMD1G, CMH9, CMPD4, EOMFC, HMERF, LGMD2J, MYLK5, TMD | titin (EC:2.7.11.1) |
C00001510
|
10376 | TUBA1B, K-ALPHA-1 | tubulin, alpha 1b |
C00001510
|
51174 | TUBD1, TUBD | tubulin, delta 1 |
C00001510
|
7991 | TUSC3, D8S1992, M33, MRT22, MRT7, N33, OST3A | tumor suppressor candidate 3 |
C00001510
|
56061 | UBFD1, UBPH | ubiquitin family domain containing 1 |
C00001510
|
29978 | UBQLN2, ALS15, CHAP1, DSK2, N4BP4, PLIC2 | ubiquilin 2 |
C00001510
|
7343 | UBTF, NOR-90, UBF, UBF-1, UBF1 | upstream binding transcription factor, RNA polymerase I |
C00001510
|
51569 | UFM1, BM-002, C13orf20 | ubiquitin-fold modifier 1 |
C00001510
|
7366 | UGT2B15, HLUG4, UDPGT_2B8, UDPGT2B15, UDPGTH3, UGT2B8 | UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) |
C00001510
|
84135 | UTP15, NET21 | UTP15, U3 small nucleolar ribonucleoprotein, homolog (S. cerevisiae) |
C00001510
|
7405 | UVRAG, DHTX, VPS38, p63 | UV radiation resistance associated |
C00001510
|
7424 | VEGFC, Flt4-L, VRP | vascular endothelial growth factor C |
C00001510
|
9559 | VPS26A, HB58, Hbeta58, PEP8A, VPS26 | vacuolar protein sorting 26 homolog A (S. pombe) |
C00001510
|
30813 | VSX1, CAASDS, KTCN, KTCN1, PPCD, PPD, RINX | visual system homeobox 1 |
C00001510
|
81554 | WBSCR16 | Williams-Beuren syndrome chromosome region 16 |
C00001510
|
91833 | WDR20, DMR | WD repeat domain 20 |
C00001510
|
55093 | WDYHV1, C8orf32 | WDYHV motif containing 1 |
C00001510
|
339005 | WHAMMP3, WHAMML1, WHDC1L1 | WAS protein homolog associated with actin, golgi membranes and microtubules pseudogene 3 |
C00001510
|
54904 | WHSC1L1, NSD3, pp14328 | Wolf-Hirschhorn syndrome candidate 1-like 1 (EC:2.1.1.43) |
C00001510
|
9589 | WTAP | Wilms tumor 1 associated protein |
C00001510
|
51741 | WWOX, D16S432E, FOR, FRA16D, HHCMA56, PRO0128, SDR41C1, WOX1 | WW domain containing oxidoreductase (EC:1.1.1.-) |
C00001510
|
331 | XIAP, API3, BIRC4, IAP-3, ILP1, MIHA, XLP2, hIAP-3, hIAP3 | X-linked inhibitor of apoptosis |
C00001510
|
9942 | XYLB | xylulokinase homolog (H. influenzae) (EC:2.7.1.17) |
C00001510
|
10413 | YAP1, YAP, YAP2, YAP65, YKI | Yes-associated protein 1 |
C00001510
|
84272 | YIPF4, FinGER4 | Yip1 domain family, member 4 |
C00001510
|
286451 | YIPF6, FinGER6 | Yip1 domain family, member 6 |
C00001510
|
91746 | YTHDC1, YT521, YT521-B | YTH domain containing 1 |
C00001510
|
10472 | ZBTB18, C2H2-171, RP58, TAZ-1, ZNF238 | zinc finger and BTB domain containing 18 |
C00001510
|
7597 | ZBTB25, C14orf51, KUP, ZNF46 | zinc finger and BTB domain containing 25 |
C00001510
|
84878 | ZBTB45, ZNF499 | zinc finger and BTB domain containing 45 |
C00001510
|
54819 | ZCCHC10 | zinc finger, CCHC domain containing 10 |
C00001510
|
79844 | ZDHHC11, ZNF399 | zinc finger, DHHC-type containing 11 (EC:2.3.1.225) |
C00001510
|
60685 | ZFAND3, TEX27 | zinc finger, AN1-type domain 3 |
C00001510
|
7542 | ZFPL1, D11S750, MCG4 | zinc finger protein-like 1 |
C00001510
|
7572 | ZNF24, KOX17, RSG-A, ZNF191, ZSCAN3, Zfp191 | zinc finger protein 24 |
C00001510
|
7574 | ZNF26, KOX20 | zinc finger protein 26 |
C00001510
|
6940 | ZNF354A, EZNF, HKL1, KID-1, KID1, TCF17 | zinc finger protein 354A |
C00001510
|
22869 | ZNF510 | zinc finger protein 510 |
C00001510
|
147947 | ZNF542 | zinc finger protein 542 |
C00001510
|
424158 |
C00001510
|
||
90592 | ZNF700 | zinc finger protein 700 |
C00001510
|
8233 | ZRSR2, U2AF1-RS2, U2AF1L2, U2AF1RS2, URP | zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2 |
C00001510
|
79364 | ZXDC, ZXDL | ZXD family zinc finger C |
C00001510
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#100100 | Abdominal muscles, absence of, with urinary tract abnormality and cryptorchidism |
P20309
|
#614613 | Acrodysostosis 2, with or without hormone resistance; acrdys2 |
Q08499
|
#219080 | Acth-independent macronodular adrenal hyperplasia; aimah |
P63092
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#103470 | Albinism, ocular, with sensorineural deafness |
P14679
|
#203100 | Albinism, oculocutaneous, type ia; oca1a |
P14679
|
#606952 | Albinism, oculocutaneous, type ib; oca1b |
P14679
|
#103780 | Alcohol dependence |
P08172
P14416 P31645 |
#612069 | Amyotrophic lateral sclerosis 10, with or without frontotemporal dementia; als10 |
Q13148
|
#614373 | Amyotrophic lateral sclerosis 16, juvenile; als16 |
Q99720
|
#600807 | Asthma, susceptibility to |
Q13093
|
#608584 | Asthma-related traits, susceptibility to, 2 |
Q6W5P4
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#614490 | Blood group, junior system; jr |
Q9UNQ0
|
#210900 | Bloom syndrome; blm |
P54132
|
#602025 | Body mass index quantitative trait locus 9; bmiq9 |
P41968
|
#114480 | Breast cancer |
P38398
|
#604370 | Breast-ovarian cancer, familial, susceptibility to, 1; brovca1 |
P38398
|
#300615 | Brunner syndrome |
P21397
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#118300 | Charcot-marie-tooth disease and deafness |
Q01453
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#118220 | Charcot-marie-tooth disease, demyelinating, type 1a; cmt1a |
Q01453
|
#114500 | Colorectal cancer; crc |
P84022
Q14191 |
#602579 | Congenital disorder of glycosylation, type ib; cdg1b |
P34949
|
#614466 | Coronary heart disease, susceptibility to, 6; chds6 |
P08254
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#612522 | Diabetes mellitus, insulin-dependent, 22; iddm22 |
P51681
|
#119900 | Digital clubbing, isolated congenital |
P15428
|
#607208 | Dravet syndrome |
P35498
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#613721 | Epileptic encephalopathy, early infantile, 11; eiee11 |
Q99250
|
#609820 | Erythrocytosis, familial, 3; ecyt3 |
Q9GZT9
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#612219 | Ewing sarcoma; es |
P11308
|
#301500 | Fabry disease |
P06280
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#613659 | Gastric cancer |
P04626
|
#137215 | Gastric cancer, hereditary diffuse; hdgc |
P04626
|
#608013 | Gaucher disease, perinatal lethal |
P04062
|
#230800 | Gaucher disease, type i |
P04062
|
#230900 | Gaucher disease, type ii |
P04062
|
#231000 | Gaucher disease, type iii |
P04062
|
#231005 | Gaucher disease, type iiic |
P04062
|
#604403 | Generalized epilepsy with febrile seizures plus, type 2; gefsp2 |
P35498
|
#231095 | Ghosal hematodiaphyseal dysplasia; ghdd |
P24557
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
O75874
P04626 |
#232300 | Glycogen storage disease ii |
P10253
|
#139393 | Guillain-barre syndrome, familial; gbs |
Q01453
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#114550 | Hepatocellular carcinoma |
P08581
|
#609423 | Human immunodeficiency virus type 1, susceptibility to |
P41597
P51681 |
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237450 | Hyperbilirubinemia, rotor type; hblrr |
Q9NPD5
Q9Y6L6 |
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#143860 | Hyperchlorhidrosis, isolated |
O43570
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#145900 | Hypertrophic neuropathy of dejerine-sottas |
Q01453
|
#259100 | Hypertrophic osteoarthropathy, primary, autosomal recessive, 1; phoar1 |
P15428
|
#146300 | Hypophosphatasia, adult |
P05186
|
#241510 | Hypophosphatasia, childhood |
P05186
|
#241500 | Hypophosphatasia, infantile |
P05186
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#147050 | Ige responsiveness, atopic; iger |
Q13093
|
#603932 | Intervertebral disc disease; idd |
P14780
|
#601626 | Leukemia, acute myeloid; aml |
P36888
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#613795 | Loeys-dietz syndrome, type 3; lds3 |
P84022
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P00533
P04626 P04637 |
#608516 | Major depressive disorder; mdd |
P08172
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#174800 | Mccune-albright syndrome; mas |
P63092
|
#613839 | Megaloblastic anemia due to dihydrofolate reductase deficiency |
P00374
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
%300852 | Mental retardation, x-linked 88; mrx88 |
P50052
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#613073 | Metaphyseal anadysplasia 2; mandp2 |
P14780
|
#603933 | Microvascular complications of diabetes, susceptibility to, 1; mvcd1 |
P15692
|
#609634 | Migraine, familial hemiplegic, 3; fhm3 |
P35498
|
#259600 | Multicentric osteolysis, nodulosis, and arthropathy; mona |
P08253
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#126200 | Multiple sclerosis, susceptibility to; ms |
P08575
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#159900 | Myoclonic dystonia |
P14416
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#162500 | Neuropathy, hereditary, with liability to pressure palsies; hnpp |
Q01453
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257200 | Niemann-pick disease, type a |
P17405
|
#607616 | Niemann-pick disease, type b |
P17405
|
#601665 | Obesity |
P32245
|
#164230 | Obsessive-compulsive disorder; ocd |
P31645
|
#604715 | Orthostatic intolerance |
P23975
|
#166350 | Osseous heteroplasia, progressive; poh |
P63092
|
#259730 | Osteopetrosis, autosomal recessive 3; optb3 |
P00918
|
#167000 | Ovarian cancer |
P04626
P38398 |
#614320 | Pancreatic cancer, susceptibility to, 4; pnca4 |
P38398
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#168600 | Parkinson disease, late-onset; pd |
P04062
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#613135 | Parkinsonism-dystonia, infantile; pkdys |
Q01959
|
#614674 | Periodic fever, menstrual cycle-dependent |
P08908
|
#172700 | Pick disease of brain |
P10636
|
#102200 | Pituitary adenoma, growth hormone-secreting |
P63092
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#614278 | Platelet-activating factor acetylhydrolase deficiency; pafad |
Q13093
|
#614390 | Pregnancy loss, recurrent, susceptibility to, 2; rprgl2 |
P00734
|
#613679 | Prothrombin deficiency, congenital |
P00734
|
#103580 | Pseudohypoparathyroidism, type ia; php1a |
P63092
|
#603233 | Pseudohypoparathyroidism, type ib; php1b |
P63092
|
#612462 | Pseudohypoparathyroidism, type ic; php1c |
P63092
|
#605074 | Renal cell carcinoma, papillary, 1; rccp1 |
P08581
|
#607276 | Resting heart rate, variation in |
P08588
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#600852 | Retinitis pigmentosa 17; rp17 |
P22748
|
#607745 | Seizures, benign familial infantile, 3; bfis3 |
Q99250
|
#608971 | Severe combined immunodeficiency, autosomal recessive, t cell-negative, b cell-positive, nk cell-positive |
P08575
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#601800 | Skin/hair/eye pigmentation, variation in, 3; shep3 |
P14679
|
#253300 | Spinal muscular atrophy, type i; sma1 |
Q16637
|
#253550 | Spinal muscular atrophy, type ii; sma2 |
Q16637
|
#253400 | Spinal muscular atrophy, type iii; sma3 |
Q16637
|
#271150 | Spinal muscular atrophy, type iv; sma4 |
Q16637
|
#605361 | Spinocerebellar ataxia 14; sca14 |
P05129
|
#183090 | Spinocerebellar ataxia 2; sca2 |
Q99700
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601367 | Stroke, ischemic |
P00734
P16109 P24723 |
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#188050 | Thrombophilia due to thrombin defect; thph1 |
P00734
|
#190300 | Tremor, hereditary essential, 1; etm1 |
P35462
|
#138900 | Uric acid concentration, serum, quantitative trait locus 1; uaqtl1 |
Q9UNQ0
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#277700 | Werner syndrome; wrn |
Q14191
|
#610379 | West nile virus, susceptibility to |
P51681
|
#278300 | Xanthinuria, type i |
P47989
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
#112100 | Yt blood group antigen |
P22303
|
KEGG | name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H01302 | Hyperchlorhidrosis isolated (HCHLH) |
O43570
(related)
|
H00021 | Renal cell carcinoma |
O43570
(marker)
P04637 (marker) P08581 (related) P15692 (marker) Q16790 (marker) |
H01197 | Dihydrofolate reductase (DHFR) deficiency |
P00374
(related)
|
H00016 | Oral cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00017 | Esophageal cancer |
P00533
(related)
P04637 (related) P04637 (marker) P35354 (related) |
H00018 | Gastric cancer |
P00533
(related)
P04626 (related) P04637 (related) P08581 (related) P10415 (related) P15692 (related) |
H00022 | Bladder cancer |
P00533
(related)
P04626 (related) P04637 (related) |
H00028 | Choriocarcinoma |
P00533
(related)
P03956 (related) P04626 (related) P04637 (related) P08253 (related) P10415 (related) |
H00030 | Cervical cancer |
P00533
(related)
P04626 (related) P10415 (related) |
H00042 | Glioma |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00055 | Laryngeal cancer |
P00533
(related)
P00533 (marker) P04637 (related) P04637 (marker) |
H00223 | Inherited thrombophilia |
P00734
(related)
|
H01254 | Congenital prothrombin deficiency |
P00734
(related)
|
H00241 | Combined proximal and distal renal tubular acidosis (RTA type 3) |
P00918
(related)
|
H00436 | Osteopetrosis |
P00918
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
Q01453 (related) |
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
|
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04626 (related) P04637 (related) Q92731 (marker) |
H00066 | Lewy body dementia (LBD) |
P04062
(related)
|
H00126 | Gaucher disease |
P04062
(related)
|
H00426 | Defects in the degradation of ganglioside |
P04062
(related)
|
H00810 | Progressive myoclonic epilepsy (PME) |
P04062
(related)
|
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00019 | Pancreatic cancer |
P04626
(related)
P04637 (related) P04637 (marker) |
H00027 | Ovarian cancer |
P04626
(related)
P04637 (related) P38398 (related) |
H00031 | Breast cancer |
P04626
(related)
P04626 (marker) P04637 (related) P38398 (related) |
H00046 | Cholangiocarcinoma |
P04626
(related)
P04637 (related) P08581 (related) P35354 (related) |
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
P10415 (related) P28907 (marker) |
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
P10415 (related) |
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) P08253 (related) P14780 (related) P35354 (related) |
H00029 | Vulvar cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
|
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
P14679 (marker) |
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
P10415 (related) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
P05129
(related)
Q99700 (related) Q9NUW8 (related) |
H00213 | Hypophosphatasia |
P05186
(related)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00125 | Fabry disease |
P06280
(related)
|
H00079 | Asthma |
P07550
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00472 | Torg-Winchester syndrome |
P08253
(related)
|
H00091 | T-B+Severe combined immunodeficiencies (SCIDs) |
P08575
(related)
|
H00069 | Glycogen storage diseases (GSD) |
P10253
(related)
|
H00054 | Nasopharyngeal cancer |
P10415
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
Q13148 (related) |
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00023 | Testicular cancer |
P10696
(marker)
|
H00024 | Prostate cancer |
P11308
(related)
|
H00035 | Ewing's sarcoma |
P11308
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00168 | Oculocutaneous albinism (OCA) |
P14679
(related)
|
H00479 | Metaphyseal dysplasias |
P14780
(related)
|
H00457 | Primary hypertrophic osteoarthropathy (PHO) |
P15428
(related)
|
H01246 | Isolated congenital nail clubbing (ICNC) |
P15428
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00137 | Niemann-Pick disease (NPD) typeA and B |
P17405
(related)
|
H00424 | Defects in the degradation of sphingomyelin |
P17405
(related)
|
H00548 | Brunner syndrome |
P21397
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00527 | Retinitis pigmentosa (RP) |
P22748
(related)
|
H01031 | Orthostatic intolerance (OI) |
P23975
(related)
|
H00490 | Diaphyseal dysplasia with anemia (Ghosal) |
P24557
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00118 | Congenital disorders of glycosylation (CDG) type I |
P34949
(related)
|
H00775 | Familial or sporadic hemiplegic migraine |
P35498
(related)
|
H00783 | Febrile seizures |
P35498
(related)
|
H00003 | Acute myeloid leukemia (AML) |
P36888
(related)
Q01196 (related) Q01196 (marker) Q13951 (marker) |
H00192 | Xanthinuria |
P47989
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
P50052
(related)
Q99714 (related) |
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
Q14191 (related) |
H00244 | Pseudohypoparathyroidism |
P63092
(related)
|
H00441 | Progressive osseous heteroplasia (POH) |
P63092
(related)
|
H00501 | Fibrous dysplasia, polyostotic |
P63092
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H01296 | Hereditary neuropathy with liability to pressure palsies (HNPP) |
Q01453
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00408 | Type I diabetes mellitus |
Q04759
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00455 | Spinal muscular atrophy (SMA) |
Q16637
(related)
|
H00606 | Early infantile epileptic encephalopathy |
Q99250
(related)
|
H00806 | Benign familial neonatal and infantile epilepsies |
Q99250
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H00236 | Congenital polycythemia |
Q9GZT9
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MESH or OMIM | name |
KNApSAcK
metabolite |
---|---|---|
D009362 | Neoplasm Metastasis |
C00000947
C00001510 |
D009422 | Nervous System Diseases |
C00001510
|
D002471 | Cell Transformation, Neoplastic |
C00000947
|
D003556 | Cystitis |
C00000947
|
D056486 | Drug-Induced Liver Injury |
C00000947
|
D034381 | Hearing Loss |
C00000947
|
D006331 | Heart Diseases |
C00000947
|
D020138 | HYPERHOMOCYSTEINEMIA |
C00000947
|
D008107 | Liver Diseases |
C00000947
|
D017114 | Liver Failure, Acute |
C00000947
|
D008113 | Liver Neoplasms |
C00000947
|
D008325 | Mammary Neoplasms, Experimental |
C00000947
|
D050197 | Atherosclerosis |
C00000947
|
D000138 | Acidosis |
C00001510
|
D058186 | Acute Kidney Injury |
C00001510
|
C538231 | Adenocarcinoma of lung |
C00001510
|
D000402 | Airway Obstruction |
C00001510
|
D001018 | Aortic Diseases |
C00001510
|
D001049 | Apnea |
C00001510
|
D001145 | Arrhythmias, Cardiac |
C00001510
|
D001167 | Arteritis |
C00001510
|
D001247 | Asthenia |
C00001510
|
D001249 | Asthma |
C00001510
|
D001927 | Brain Diseases |
C00001510
|
D001930 | Brain Injuries |
C00001510
|
D001986 | Bronchial Spasm |
C00001510
|
D001991 | Bronchitis |
C00001510
|
D029481 | Bronchitis, Chronic |
C00001510
|
D009202 | Cardiomyopathies |
C00001510
|
D002318 | Cardiovascular Diseases |
C00001510
|
D002375 | Catalepsy |
C00001510
|
D002543 | Cerebral Hemorrhage |
C00001510
|
D002637 | Chest Pain |
C00001510
|
D002653 | Child Behavior Disorders |
C00001510
|
D002819 | Chorea |
C00001510
|
D019970 | Cocaine-Related Disorders |
C00001510
|
D003128 | COMA |
C00001510
|
D017714 | Community-Acquired Infections |
C00001510
|
D003221 | Confusion |
C00001510
|
D003693 | Delirium |
C00001510
|
D003866 | Depressive Disorder |
C00001510
|
D004310 | Double Outlet Right Ventricle |
C00001510
|
D062787 | Drug Overdose |
C00001510
|
D064420 | Drug-Related Side Effects and Adverse Reactions |
C00001510
|
D004409 | Dyskinesia, Drug-Induced |
C00001510
|
D004417 | Dyspnea |
C00001510
|
D004487 | Edema |
C00001510
|
D004646 | Emphysema |
C00001510
|
D004830 | Epilepsy, Tonic-Clonic |
C00001510
|
D004935 | Esophageal Diseases |
C00001510
|
D020329 | Essential Tremor |
C00001510
|
D005119 | Extravasation of Diagnostic and Therapeutic Materials |
C00001510
|
D005221 | Fatigue |
C00001510
|
D005334 | Fever |
C00001510
|
D005767 | Gastrointestinal Diseases |
C00001510
|
D006029 | Glycosuria |
C00001510
|
D006212 | Hallucinations |
C00001510
|
D006261 | Headache |
C00001510
|
D006319 | Hearing Loss, Sensorineural |
C00001510
|
D006323 | Heart Arrest |
C00001510
|
D006327 | Heart Block |
C00001510
|
D006330 | Heart Defects, Congenital |
C00001510
|
D006470 | Hemorrhage |
C00001510
|
D006519 | Hepatitis, Alcoholic |
C00001510
|
D006930 | Hyperalgesia |
C00001510
|
D006934 | Hypercalcemia |
C00001510
|
D053565 | Hypercalciuria |
C00001510
|
D006940 | Hyperemia |
C00001510
|
D006943 | Hyperglycemia |
C00001510
|
D006948 | Hyperkinesis |
C00001510
|
D006973 | Hypertension |
C00001510
|
D006984 | Hypertrophy |
C00001510
|
D007008 | Hypokalemia |
C00001510
|
D018476 | Hypokinesia |
C00001510
|
D007010 | Hyponatremia |
C00001510
|
D017674 | Hypophosphatemia |
C00001510
|
D007022 | Hypotension |
C00001510
|
D007174 | Impulse Control Disorders |
C00001510
|
D007177 | Inappropriate ADH Syndrome |
C00001510
|
D007232 | Infant, Newborn, Diseases |
C00001510
|
D007235 | Infant, Premature, Diseases |
C00001510
|
D007248 | Infertility, Male |
C00001510
|
D007249 | Inflammation |
C00001510
|
D007674 | Kidney Diseases |
C00001510
|
D007859 | Learning Disorders |
C00001510
|
D053609 | Lethargy |
C00001510
|
D015451 | Leukemia, Lymphocytic, Chronic, B-Cell |
C00001510
|
D007945 | Leukemia, Lymphoid |
C00001510
|
D007964 | Leukocytosis |
C00001510
|
D008173 | Lung Diseases, Obstructive |
C00001510
|
D008175 | Lung Neoplasms |
C00001510
|
D008569 | Memory Disorders |
C00001510
|
D008659 | Metabolic Diseases |
C00001510
|
D019964 | Mood Disorders |
C00001510
|
D016183 | Murine Acquired Immunodeficiency Syndrome |
C00001510
|
D009127 | Muscle Rigidity |
C00001510
|
D017202 | Myocardial Ischemia |
C00001510
|
D009212 | Myoglobinuria |
C00001510
|
D009325 | Nausea |
C00001510
|
D009374 | Neoplasms, Experimental |
C00001510
|
D001943 | Breast Neoplasms |
C00000947
|
D000857 | Olfaction Disorders |
C00001510
|
D009846 | Oliguria |
C00001510
|
D010409 | Penile Diseases |
C00001510
|
D011014 | Pneumonia |
C00001510
|
D051299 | Post-Dural Puncture Headache |
C00001510
|
D011297 | Prenatal Exposure Delayed Effects |
C00001510
|
D011595 | Psychomotor Agitation |
C00001510
|
D029424 | Pulmonary Disease, Chronic Obstructive |
C00001510
|
D051437 | Renal Insufficiency |
C00001510
|
D015427 | Reperfusion Injury |
C00001510
|
D012120 | Respiration Disorders |
C00001510
|
D012133 | Respiratory Paralysis |
C00001510
|
D012206 | Rhabdomyolysis |
C00001510
|
D012640 | Seizures |
C00001510
|
D012893 | Sleep Disorders |
C00001510
|
D012912 | Sneezing |
C00001510
|
D013035 | Spasm |
C00001510
|
D013036 | Spasms, Infantile |
C00001510
|
D046628 | Sphincter of Oddi Dysfunction |
C00001510
|
D013119 | Spinal Cord Injuries |
C00001510
|
D013163 | Splenomegaly |
C00001510
|
D013226 | Status Epilepticus |
C00001510
|
D013342 | Stuttering |
C00001510
|
D013375 | Substance Withdrawal Syndrome |
C00001510
|
D019462 | Syncope, Vasovagal |
C00001510
|
D013610 | Tachycardia |
C00001510
|
D013614 | Tachycardia, Paroxysmal |
C00001510
|
D013616 | Tachycardia, Sinus |
C00001510
|
D013617 | Tachycardia, Supraventricular |
C00001510
|
D014188 | Transposition of Great Vessels |
C00001510
|
D014202 | Tremor |
C00001510
|
D014549 | Urinary Incontinence |
C00001510
|
D016055 | Urinary Retention |
C00001510
|
D014839 | Vomiting |
C00001510
|